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The ubiquity and persistence of regional variation in healthcare utilization have been studied 
and widely documented in the last decades, and raise increasing attention and concerns from 
health services researchers, healthcare professionals as well as health policymakers. The 
observed regional variation may to a substantial extent reflect suboptimal healthcare use due to 
unequal access to care, which could result in detrimental consequences to the quality, equity, 
and efficiency of healthcare. Regional variation in healthcare utilization could be driven by 
multiple factors, including individual’s socio-demographic and clinical characteristics, 
physician/facility availability, as well as healthcare system-related factors. Among the potential 
drivers, the systematic ones (e.g. health insurance-related factors) should be particularly 
focused on, because they offer the most potential for widespread improvement. Changing the 
laws, initiation of national programs, or adjusting insurance schemes are big levers to reduce 
variation on a national level.  
Existing studies on regional variation analysis of healthcare utilization mainly focused on 
detecting the existence and evaluating the degree of regional variation in healthcare utilization, 
and they had several limitations. First, numerous analyses were focusing on only one region of 
a country, without nationwide coverage. Second, the selection of studied healthcare services 
was often arbitrary and opportunity driven. Third, the potential causes and drivers of variation 
were rarely explored. The majority of studies used conventional small area variation analysis 
(SAVA), and only a few studies controlled for a limited number of possible influencing factors. 
Finally, most studies investigated only one healthcare service, or one category of similar 
services, without comparison across diverse services to explore the potential common patterns. 
The evidence is stronger if influencing factors show consistent effects across multiple 
healthcare services. 
This thesis addresses the above-mentioned problems as much as possible. The overall aim was 
to assess regional variation and potential influencing factors, especially health insurance-related 
factors, of the utilization of diverse healthcare services with Swiss claims data, using a 
comprehensive analysis approach developed based on the existing methods. The thesis consists 
of three articles: in the first one preoperative chest radiography was used as a test case to 
develop the analysis approach based on the existing methods of healthcare regional variation 
analysis including small area variation analysis, multilevel regression analysis, and spatial 
autocorrelation analysis. In the second article I applied the approach to four management 
measures strongly recommended for diabetes patients. Besides, multilevel regression modelling 
was extended by taking spatial autocorrelation into consideration, as an additional exploration 
for evaluating spatial clustering patterns in healthcare utilization. In the third article I applied 
the comprehensive approach to 24 healthcare services, and summarized and compared findings 
across all these services. Regional variation after controlling for multiple influencing factors 
was generally small among all selected services. The most interesting finding was the 
substantial and consistent effects of health insurance-related factors among most services. A 
higher annual deductible level was mostly associated with lower utilization. Supplementary 
insurance, supplementary hospital insurance, and having chosen a managed care model were 
associated with higher utilization of most services. Managed care models showed a tendency 
towards more recommended care. 
The findings implied that it could be a potential way to improve healthcare utilization through 
adjustment of insurance scheme design, which may further benefit the quality, equity, and 
efficiency of the healthcare system, and may also inform health policy formulation. The 
comprehensive approach aids in the identification of regional variation and influencing factors 
of healthcare services use in Switzerland as well as comparable settings worldwide.  Built on 
the current study findings, further research could focus on exploring potential spatial clustering 
patterns in the utilization across multiple healthcare services, and identifying specific regions 
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Regional variation in healthcare utilization 
Importance and relevance of regional variation analysis  
The ubiquity and persistence of variation in healthcare utilization across geographic regions has 
raised awareness and concerns from healthcare professionals, health services researchers, and 
policymakers since decades ago, and are receiving more and more attention nowadays. 
Regional variation in healthcare utilization potentially caused by unequal access to care or 
various clinical practice styles raises concerns regarding the equity, quality, and efficiency of 
the healthcare system, and may result in detrimental consequences in both health outcomes and 
healthcare expenditures [1]. From a health policy perspective and concerning the healthcare 
system performance, it is fundamental to detect the existence and evaluate the degree of 
regional variation, and more importantly, to investigate potential drivers of regional variation 
in healthcare utilization, that is, to find out if regional variation is justified by the underlying 
medical need, or if it is a sign of misallocation of healthcare resources or inappropriate 
healthcare use such as over- and underuse [2]. Therefore, research on regional variation in 
healthcare utilization is of great significance, and it helps identify potential influencing factors 
and problematic regions, and could further provide insights to health policymaking and targeted 
intervention programs [3]. 
Documented large regional variation 
Considerable regional variations in the utilization of healthcare services has been studied and 
widely documented by researchers worldwide. As one of the leading pioneers, John Wennberg 
and the Dartmouth Institute has done a lot of conceptual and methodological work on research 
of variation in healthcare utilization [4-7]. The Dartmouth Atlas of Health Care Project [8], 
which was led by John Wennberg and launched more than 20 years ago, has documented 
glaring variation across the US regions in the utilization of different types of healthcare 
services, such as surgical procedures, post-acute care, end of life care, etc. [9-11]. Influenced 
by the Dartmouth Atlas of Health Care, researchers and policymakers across the globe have 
recognized the importance of regional variation in healthcare utilization, and several countries 
and regions have also created their own atlases of healthcare, including Canada [12], Australia 





Large and potentially inappropriate regional variation in preventive interventions, screening 
and diagnostic tests, pharmaceutical prescriptions, and surgical procedures has been described 
all over the world [3, 19]. Variation in influenza vaccination was as high as 15-fold across 
regions in Michigan as observed in a study from the US [20]. A study reported a three-fold 
difference in mammography for breast cancer screening across multiple countries from Europe, 
Asia, and North America [21]; another study from Canada reported a 50-fold difference in MRI 
scans for breast cancer pre-diagnosis across Ontario [22]. Research on surgical procedures 
mainly focused on elective procedures. After adjusting for socio-demographic, hospital, and 
distance variables, regional variation in elective primary hip and knee replacement was almost 
three-fold in the UK [23]; another study from Korea showed a four-fold regional variation in 
knee arthroplasty [24]. Two studies on caesarean section reported considerable regional 
variation in a few European countries and the US [25, 26]. For Switzerland, a large degree of 
variation in the use of hysterectomy has been reported as early as 1988 [27]. Marked regional 
variation in healthcare utilization between the German- and French-speaking parts of 
Switzerland has been noted, for example, in the prescription of antibiotics [28]. Swiss studies 
also observed regional variation in avoidable hospitalizations and end-of-life care for cancer 
patients [29, 30].  
Warranted and unwarranted regional variation  
Part of the observed variation in healthcare utilization across regions could be justified by 
patient needs or preferences, and it is defined as warranted variation. However, it has been 
suggested that regional variation reported in studies was too large to be simply explained by 
variation in the actual care needs of different populations [31]. Therefore, the ubiquitous and 
large regional variation may to a substantial extent reflect inappropriate healthcare use, which 
may be over- or underuse. The term of unwarranted variation was coined by John Wennberg, 
and was defined as the regional variation in healthcare utilization that is not due to patient needs 
or preferences [32]. Unwarranted variation reveals three areas: overuse of healthcare such that 
more harm than good is done; underuse of healthcare such that cost-effective services are not 
performed sufficiently; inequity of healthcare such that services are not accessible to parts of 
the population, possibly because of their social background. 
John Wennberg and colleagues have proposed three categories of healthcare services of which 
the causes and remedies of unwarranted variation may differ [33]. Effective care is the services 




they should be received by all eligible patients. Theoretically, utilization rates should be close 
to 100%, and the common problem is underuse. Effective care is normally recommended in 
clinical guidelines with high-level evidence and class Ⅰ recommendation (namely there is 
evidence and/or general agreement that a given treatment or procedure is beneficial, useful, and 
effective). For example, two crucial diabetes management measures - biannual glycated 
haemoglobin testing and annual eye examination are strongly recommended to all patients with 
diabetes by both Swiss and international guidelines [34-36]. The second type is preference-
sensitive care, or elective care, for which there are multiple options of healthcare services to 
the same condition, and the decision largely depends on patient preferences. However, the 
decision is practically determined by physician opinion (or physician judgement) rather than 
patient preferences. John Wennberg called for a change in the physician-patient relationship to 
enhance the role of patient and support more informed patient choice [32]. For example, 
whether having caesarean section or vaginal delivery is normally a shared decision between the 
patient and the physician when there is no absolute indication for caesarean section. The third 
type is supply-sensitive care, which is not about a certain healthcare service per se, but the 
frequency of healthcare that is used routinely to treat patients. Examples of such care include 
physician visits, hospital admissions, intensive care unit admission, imaging exams. Local 
capacity and availability of specialists or facilities drive the use [32].  
Although the categorization of healthcare services provides an analytical framework for 
understanding and investigating healthcare variation, it is not straightforward to determine the 
category of a specific healthcare service and on many occasions the three categories are not 
mutually exclusive. For instance, influenza vaccination is recommended to all elderly (>65) 
people and patients with certain chronic conditions [37]. However, the decision to get 
vaccinated depends on the patient’s preferences to a large extent. Another example is imaging 
services for disease diagnosis with well-proven effectiveness, but the decision on the utilization 
could be largely influenced by the local resource capacity of imaging equipment.  
Influencing factors of regional variation 
To minimize unwarranted variation in healthcare utilization across regions, it is vital to explore 
and understand potential influencing factors. Regional variation in healthcare utilization may 
be driven by multiple factors, including patient socio-demographics, clinical characteristics, 




function as personal, financial, and organizational modifiers of access to care [38]. Figure 1 
presents the mapping of potential influencing factors for regional variation in healthcare 
utilization, based on a more comprehensive graphical overview of potentially relevant 
influences in the UK by Appleby et al. [31]. 




Patients’ demographic, socioeconomic, and clinical characteristics have been found to be 
associated with regional variation in healthcare utilization. A German study found that social 
variables such as gender and mother language of parents had an impact on variation in child 
vaccination rates across different school districts [39]. Studies also reported that regional 




socioeconomic status, education, and urban-rural resident location [40-42]. A review on the 
utilization of common surgical procedures reported that the involvement of patient preferences 
into treatment decisions could result in regional variation [43].  
Provider-related factors 
Not many studies have investigated the influence of physicians’ characteristics on regional 
variation in healthcare utilization, such as their awareness and preferences on clinical practice 
guidelines. One study found that physician beliefs about the surgery indications could influence 
the utilization and regional variation in the utilization of surgical procedures [43]. Besides, the 
local healthcare resources and accessibility [44, 45], and lack of or poor adherence to guidelines 
[46] are also important drivers of regional variation. 
Healthcare system-related factors: the Swiss setting 
Healthcare system-related factors including health insurance schemes, health policies, and 
national legislation or programs are of great importance, because their modification may offer 
big levers to reduce unwarranted variation at a national level. However, very few studies have 
investigated their effects on regional variation in healthcare utilization. Most of the available 
studies which were mainly conducted in the US only concluded that the uninsured patients had 
lower healthcare utilization compared to the insured patients or patients with private insurance 
[47, 48].  
Switzerland has a system with universal care access and high out-of-pocket expenditures. 
Although no free healthcare services are provided by the state, basic health insurance from one 
of the private insurers is compulsory for all residents in Switzerland. While non-insurance does 
practically not occur in Switzerland, foregoing healthcare due to out-of-pocket payments is a 
well-documented phenomenon [49]. However, part of the cost of the services received is paid 
by the patient insured, which is done by means of an annual deductible ranging from 300 to 
2500 Swiss francs. Insurance companies offer the standard basic insurance model (with free 
choice of physicians) and alternative insurance models (i.e. managed care models) including 1) 
the Health Maintenance Organisation (HMO) model, under which the patient has to always first 
consult a specific HMO centre in the event of illness; 2) family doctor model, under which the 
patient has to first contact his or her family doctor in the event of illness; 3) Telemedicine 
model, under which the patient has to call a telephone service and get a referral to a doctor or 




reductions of up to 25 percent on basic health insurance compared to the standard model. In 
addition to the basic health insurance, people are also provided with various options of 
supplementary insurance such as dental insurance, and supplementary hospital insurance which 
allows for hospitalization in semiprivate or private wards. The benefit package in the basic 
mandatory health insurance is the same for everybody, defined by federal law, which makes 
Switzerland an interesting case for studying other effects.  
Methods of regional variation analysis 
Small area variation analysis 
Analysis of variation in healthcare utilization across regions or healthcare providers has led to 
the development of small area variation analysis (SAVA) since the 1980s. SAVA is a very 
popular methodology in health services research to describe how healthcare utilization rates 
vary across well-defined small geographic regions [51]. In addition to the simple descriptive 
statistics normally used in SAVA including range, interquartile range (IQR), extremal quotient 
(EQ), standard deviation (SD), and coefficient of variation (CV), a complicated and much more 
reliable measure has been developed - systematic component of variation (SCV). Compared to 
the simple descriptive statistics, one of the key advantages of SCV is that it facilitates 
comparison of utilization rates between geographic units of different population size and for 
interventions of different frequency, by removing the random component of variation, [52, 53]. 
SCV has been demonstrated to perform generally well in the identification and quantification 
of variation beyond chance, and could be used to compare the variability of different healthcare 
services [54, 55]. The Empirical Bayes statistic represents a relevant alternative, and non-
parametric bootstrapping techniques have been recommended for confidence interval 
estimation [55]. Age- and gender differences between populations of different geographic units 
are taken into account in the calculation of SCV, based on standardization techniques [31, 52]. 
SCV has become one of the most widely used measure when describing regional variation in 
healthcare utilization, and has been applied in numerous studies [31, 43, 56]. The complexity 











Multilevel regression analysis and further potentials 
In spite of the good performance of SCV, it lacks the multivariable adjustment for other possible 
influencing factors except for age and sex. Multilevel regression analysis could serve as an 
alternative that allows for exploring the effects of multiple influencing factors on regional 
variation at different levels (e.g. patient, healthcare provider, and geographic unit). The 
potential role of multilevel regression analysis in health services research and specifically in 
the analysis of regional variation has been mentioned previously [57], and a number of studies 
have pursued approaches of this type [58-60], including a recent Swiss study applying 
multilevel approach to regional variation analysis in vertebroplasty and kyphoplasty [61].  
The potential of this approach can be further developed, e.g. calculating median odds ratio 
(MOR) and variance partition coefficients (VPCs) based on the random effect from multilevel 
models to assess the degree of between-region variation after controlling for multiple 
influencing factors [62]. They could be compared among diverse healthcare services as the 
SAVA measures.  
Another aspect in the analysis of regional variation in healthcare utilization is the possibility of 
spatial autocorrelation between geographic units due to spill-over effect or unmeasured 
confounders [63], which could be detected by calculating Moran’s I statistic [64]. If substantial 
autocorrelation is detected, it should be taken into account in analysis to avoid incorrect 
parameter and standard error estimates, which is possible using specific extensions to regression 
techniques (e.g. spatial lag models, spatial error models) [63], or the Bayesian statistical models 
such as the Integrated Nested Laplace Approximations (INLA) approach [65-68]. 
Major concerns of previous studies 
Although there were a large number of studies on the topic of regional variation in healthcare 
utilization, they share a few common problematic issues. 
Definition of Region units and coverage 
A systematic review of variation in healthcare utilization in OECD countries reported that only 
about half of studies covered an entire country, and the rest only focused on a part of a country 
such as provinces, cities, and counties [3]. Without nationwide coverage, the benefit from the 




efficiently at a national level. The unit in regional variation analysis ranged from provinces, 
municipalities, to specific areas such as health services areas, or hospital referral regions. Using 
relatively large areas as analysis unit, e.g. states in the US, could potentially mask true variation 
across small regions. This is also the case in Switzerland where 26 cantons or canton-like 
regions have been used as the unit of regional variation analysis in most studies. The sizes of 
cantons are extremely uneven, and the potential imbalanced performance within some big 
cantons have not been explored. For example, the map of coronary bypass surgery rates in 
Switzerland from the Swiss atlas project is shown in Figure 3 [17]. The sizes of regions vary 
remarkably, and variation in the utilization of coronary bypass surgery within large regions was 
not revealed.  
Figure 3. Utilization rates of coronary bypass surgery in Switzerland [17] 
 
 
Selection of healthcare services 
The selection of studied services has often been arbitrary and opportunity driven. The majority 
of existing studies have concentrated on high-impact clinical conditions and common 
healthcare services, and many other conditions were much less often studied. The most 
frequently studied clinical conditions were cancer and cardiovascular diseases such as breast 




healthcare services ranged from physician visits, screening services, drug prescriptions to 
surgical procedures, with more than 60% of studies focusing on the use of hospitals such as 
hospital (re)admissions [3].  
Insufficient research on influencing factors 
Despite an overwhelming number of studies assessing regional variation in healthcare 
utilization, the effects of possible influencing factors were rarely studied. Adjustment for 
multiple factors has not been described for small area variation analysis, which is still the 
mainstream research tool for regional variation analysis in healthcare utilization. Although 
multilevel regression analysis provides another possibility for healthcare variation analysis, and 
especially for the exploration of potential influencing factors, only a limited number of factors 
have been controlled for in a few studies, mainly focusing on patients’ socio-demographic and 
clinical characteristics [61, 69, 70]. A thorough investigation of other healthcare system factors, 
especially health insurance-related factors, is still missing.  
Lack of cross-services comparison 
Most studies have assessed regional variation in the utilization of a single healthcare service, 
and a few studies covering multiple services only focused on one category of related services, 
for example, similar surgical procedures [52, 61]. Studies simultaneously exploring and 
comparing regional variation and influencing factors of a variety of healthcare services are 
currently missing. Systematic component of variation (SCV) in small area variation analysis 
has been applied for comparison of regional variation (controlled for only age and sex) between 
different healthcare services [31, 43, 52]. However, the effects of potential influencing factors 
and the degree of regional variation after adjusting for multiple factors across diverse healthcare 
services have not been paid much attention to. Evaluating and comparing the effects of 
influencing factors, especially health insurance-related factors, on regional variation in the 
utilization across multiple services is in particular important. If consistent effects among diverse 
services could be observed, the findings may offer valuable insights to help improve insurance 
design and the healthcare system performance.  
Limitations introduced by data availability 
Nearly half of existing studies on healthcare variation analysis used health administrative data 




data and survey data [3]. The use of health insurance claims data or similar administrative data 
for health services research and variation analysis in healthcare utilization has a longstanding 
tradition in the US [71-73] and is gaining in importance in other countries. In Switzerland, 
insurance claims data has been used in related studies, such as cantonal variation in preoperative 
chest X-ray utilization [74], regional variation of end-of-life care [30], and variation in 
healthcare expenditure [75]. Use of claims data has certain strengths, for example, it is 
convenient and timesaving to perform data collection and management; claims data usually has 
relatively good coverage of entire country and population, making it possible to conduct 
nationwide variation analysis; It also contains detailed information with regard to individual 
health insurance characteristics, which allows analysis particularly focusing on the effects of 
insurance-related factors. One of the key disadvantages of Swiss claims data is the lack of 
reliable information on diagnosis information for outpatient healthcare services. However, the 
resulting possibility of misclassification of patient identification and services utilization could 
be to some extent compensated for by evaluating the information on drug use, outpatient service 
codes, and hospitalizations. 
Justification and aims of the thesis 
This thesis is part of the National Research Programme "Smarter Health Care" (NRP74) project 
No. 26 titled “How do guidelines and recommendations influence medical treatment?”, funded 
by the Swiss National Science Foundation (SNSF). The project consisted of three parts: Part 1. 
selection of healthcare services and assessment of clinical recommendation status; Part 2. study 
of geographic variation and influencing factors for the utilization of those selected services; 
Part 3. assessment of clinical and economic outcomes. The main data used in this project is 
health insurance claims data from one of the biggest health insurance companies in Switzerland. 
The present thesis mainly focused on part 2 of this NRP74 project, namely to estimate regional 
variation in healthcare utilization and to explore influencing factors. 
Given the potential important implications that could benefit the healthcare system, and the 
major issues in current studies on regional variation in healthcare utilization described above, 
additional research is highly needed to remedy these limitations. Therefore, the present thesis 
tried to address these issues as much as possible from different perspectives.  
The overall aim of this thesis was to assess regional variation in and potential influencing 




comprehensive analysis approach. More specifically, I tried to first, develop a comprehensive 
analysis approach combining small area variation analysis, and other techniques with great 
potential in variation analysis including multilevel regression analysis and spatial 
autocorrelation analysis. Second, study on healthcare services selected through a systematic 
approach taking many aspects into consideration, including clinical and fiscal importance, 
policy relevance, public awareness, healthcare types, current medical evidence/ clinical 
recommendations, etc. The services selection is not directly a main part of the present thesis, 
and it was done within part 1 of the overall NRP74 project. Third, assess regional variation in 
healthcare utilization across the whole of Switzerland using smaller regions instead of cantons 
as region units of analysis. Fourth, investigate in detail the effects of health insurance-related 
factors on regional variation, which could provide a potential way of optimizing healthcare 
utilization and reducing unwarranted variation. At last, focus on the summary and comparison 
of results from diverse healthcare services to try to find out potential common patterns. 
Thesis outline 
Chapter Ⅱ describes regional variation in the utilization of preoperative chest radiography, 
which was used as a test case to develop a comprehensive analysis approach for regional 
variation analysis on healthcare utilization based on the existing methods. It combines small 
area variation analysis, spatial autocorrelation analysis, and multilevel regression analysis with 
the computation of median odds ratio (MOR) and 80% interval odds ratio (IOR-80) (first 
article). 
Chapter Ⅲ describes the application of the developed approach to the utilization of four 
strongly recommended diabetes management measures. Multilevel regression analysis in this 
study has been additionally extended with the Bayesian statistical model which enables 
correcting for spatial autocorrelation and evaluating spatial clustering patterns in healthcare 
utilization (second article). 
Chapter Ⅳ compares and summarizes the degree of regional variation and the effects of 
potential influencing factors on the utilization of 24 healthcare services of interest, and 





Chapter Ⅴ summarizes the main findings of the three chapters and discusses the contribution to 
health services research, more specifically to the analysis of regional variation in healthcare 
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Clinical recommendations discourage routine use of preoperative chest radiography (POCR). 
However, there remains much uncertainty about its utilization, especially variation across small 
areas. We aimed to assess the variation of POCR use across small regions, and to explore its 
influencing factors. 
Patients undergoing inpatient surgery during 2013 to 2015 were identified from insurance 
claims data. Possible influencing factors of POCR included socio-demographics, health 
insurance choices, and clinical characteristics. We performed multilevel modelling with region 
and hospital as random effects. We calculated 80% interval odds ratios (IOR-80) to describe 
the effect of hospital type, and median odds ratios (MOR) to assess the degree of higher level 
variation. Utilization rates of POCR varied from 2.5% to 44.4% across regions. Higher age, 
intrathoracic pathology, and multi-morbidity were positively associated with the use of POCR. 
Female gender, choice of high franchise and supplementary hospital insurance showed a 
negative association. MOR was 1.25 and 1.69 for region and hospital levels, respectively. IOR-
80s for hospital type were wide and covered the value of one. 
We observed substantial variation of POCR utilization across small regions in Switzerland. 
Even after controlling for multiple factors, variation across small regions and hospitals 



















Preoperative chest radiography (POCR) is an example of a frequently overused healthcare 
service, discouraged by international clinical practice guidelines [1]. The Choosing Wisely 
initiative [2] launched in the US called for more caution in the use of POCR for asymptomatic 
patients due to its potential uselessness, harm and cost [3]. POCR has been shown to have 
negligible influence on subsequent patient management as well as clinical outcomes, and to 
result in significant costs [4-7]. A Swiss version of the Choosing wisely – “Smarter Medicine” 
initiative was launched by the Society for General Internal Medicine (SGAIM) in May 2014 
[8]. Avoidance of POCR for asymptomatic patients is among the top five recommendations 
published by the SGAIM in May 2016 addressing the overuse of healthcare services [9]. 
A recent study by Blozik et al. investigated the degree and geographic distribution of POCR 
utilization in Switzerland across large geographic units. Excessive use of POCR was 
undetectable in that study, but it demonstrated significant variation in the utilization rates (6% 
- 28%) at the cantonal level [10]. However, differences between smaller geographic regions 
were not explored. Summary measures such as national or cantonal POCR utilization rates may 
mask local trends and true distribution patterns. In Switzerland, there have been no cantonal 
policy or regulation regarding POCR which might be the driver of utilization variation, and we 
assume there could be significant within canton variation of POCR use in small regions. 
Analysis of variation of healthcare utilization in smaller geographic areas has considerable 
potential to support the planning and delivery of healthcare, through offering valuable insights 
to health professionals, health policymakers and the general public [11, 12].  
Different factors (patient, provider, and region-specific characteristics) may affect POCR 
utilization, which has not been fully explored to date. One study on preoperative testing before 
low-risk surgical procedures in Canada showed that POCR utilization was associated with age, 
preoperative anaesthesia consultation, preoperative medical consultation and healthcare 
institution [13]. However, the authors did not take the potential impact of health insurance 
characteristics or patients’ residence into consideration. 
The utilization of this potentially avoidable procedure across small areas in Switzerland remains 
uncertain. Building on the work by Blozik et al. [10], which provided the first overview of 
POCR utilization in Switzerland, we proceeded to an explicit small area analysis of POCR 




across 106 Spatial Mobility regions (MS regions), and to investigate the patient, hospital and 
regional factors potentially influencing POCR utilization and variation in Switzerland. 
Material and methods 
Study population 
We studied patients who received Swiss mandatory health insurance (Obligatorische 
Krankenpflegeversicherung, OKP) from the Helsana Group. Helsana is one of the largest health 
insurance companies in Switzerland, and the Helsana database underlying this study included 
mandatory health insurance claims from approximately 1.2 million people per year, covering 
about 15% of the whole Swiss population. The study population was patients enrolled with 
Helsana who were older than 18 years and underwent non-emergency inpatient surgery from 
2013 to 2015. We excluded patients with incomplete coverage of mandatory health insurance 
during 2013 and 2014, asylum seekers, patients living outside Switzerland, Helsana employees, 
patients with incomplete address information, patients living in nursing homes with lump-sum 
reimbursement of medication, and emergency inpatient stays. Only the first hospitalization per 
person during the study period was considered. The data used in the present study was the same 
as that in the study by Blozik et al. [10]. 
Basic health insurance bought from a private market of health insurance companies is 
mandatory for all Swiss residents. The insurance companies are obliged to offer mandatory 
health insurance at the same price to everyone regardless of their health status. Premiums are 
lower for children and young adults, and they differ between geographic regions. All 
appropriate and cost-effective inpatient or outpatient medical treatments are covered by 
mandatory health insurance. Supplementary hospital insurance is optional and allows for 
hospitalization in a semiprivate or private ward and treatment in another canton [14]. Enrolees 
can choose between various annual deductible costs (i.e., a “franchise”) ranging from 300 to 
2,500 Swiss Francs. The higher the franchise chosen, the lower the premium to pay. There are 
managed care and standard fee-for-service models of mandatory health insurance. Insured 
people selecting managed care models have to first consult a specific type of healthcare 
provider (i.e., a group practice, a defined family doctor, or a telemedicine centre). [14, 15] Thus 
insured people with managed care models pay fewer premiums compared to standard model 
users while they use the same fee-for-service tariff. 
The study data provided by Helsana were anonymized. According to the national ethical and 




by a waiver of the competent ethics committee (Kantonale Ethikkommission Zürich, waiver 
dated 11th January 2017). 
Outcome and explanatory variables 
The outcome variable was the performance of ambulatory chest radiography within two months 
before any inpatient surgery [16]. Inpatient surgeries were derived from the Swiss Diagnosis 
Related Groups (DRG) code. Possible influencing factors for POCR performance selected were 
based on the previous, similar literature [10, 13] or were persumed to be logic,  they included:  
1) Socio-demographic characteristics, including age, gender, language region (German, French 
or Italian), purchasing power index per household (describing the per capita income of a postal 
code region as a proxy for the socioeconomic status of the respective region), and urban or rural 
residence;  
2) Health insurance characteristics, including insurance coverage: only mandatory health 
insurance or also supplementary health insurance, e.g. the supplementary hospital care 
insurance, high franchise (more than 500 Swiss Francs), and standard or managed care 
insurance models;  
3) Type of hospital performing surgery. The four hospital types were central hospital (offering 
the highest level of healthcare services, including university hospitals), primary hospital, 
surgical hospital and other specialized clinic – as categorized by the Swiss Federal Statistical 
Office (SFSO);  
4) Clinical characteristics, for instance, multi-morbidity, indication of intrathoracic pathology 
(patients with either cardiovascular disease or respiratory disease based on pharmaceutical cost 
groups). Since Swiss health insurance claims data do not have a meaningful degree of 
diagnostic data for outpatient services, pharmaceutical cost groups (PCG) are used to deduce 
chronic morbidity at the patient level based on drug use [17]. Multi-morbidity was defined as 
the presence of at least two PCGs. 
Geographic unit 
Instead of the 26 Swiss cantons, we used 106 MS regions as the geographic units for small area 
analysis of POCR utilization and variation. MS regions are defined by the SFSO and used in 
particular as a microregional intermediate level for numerous scientific and regional policy 




small-scale labor market areas [18]. Each patient’s residence was assigned to the corresponding 
MS region in the claims data. 
Statistical analysis 
First, we performed a descriptive analysis of the eligible patients’ characteristics, including 
their socio-demographic, insurance, clinical and hospital characteristics. Second, to have an 
intuitive, visual impression of the detailed distribution of POCR utilization in Switzerland, we 
aggregated the patient level outcome and explanatory variables at the MS regional level. 
Specifically, for each MS region, we calculated the POCR rate, mean age, percentage of 
women, mean purchasing power index per household, percentage of patients with high 
franchise and with standard fee-for-service model in the mandatory health insurance, with only 
mandatory insurance, with supplementary hospital care insurance, with indication of 
intrathoracic pathology, with multi-morbidity. We also assessed the percentage of patients 
receiving surgery in each hospital type. We then mapped all relevant variables using the 
Geographic Information System (GIS) software package QGIS (version 2.14.16) [19] to show 
their geographic distribution. Third, to explore the spatial autocorrelation present in these 
variables, we computed the Moran’s I statistic and calculated Local Indicators of Spatial 
Association (LISA) using GeoDa (version 1.10) [20] that were subsequently mapped with GIS. 
Moran’s I measures the correlation of a variable with itself through space, it ranges from -1 to 
1. If the value of Moran’s I is zero or very close to 0 (p>0.05), it suggests there is no spatial 
autocorrelation (null hypothesis: the variable is totally randomly distributed through space). If 
Moran’s I is positive (p<0.05), it indicates there is positive spatial autocorrelation, namely the 
variable of one region is more similar to the regions close to it compared to regions far from it, 
and the vice versa if Moran’s I is negative. LISA shows exactly where the significant spatial 
clustering or dispersion happens locally. 
To investigate the factors that potentially affected the utilization of POCR, we first conducted 
logistic regression at the patient level to describe the associations between use of POCR and all 
potential predictors other than the geographic unit of residence. We applied a manual, step-by-
step variable selection process to develop a multivariable logistic regression model with only 
the relevant variables (with a significant coefficient, p<0.05). This multivariable model was 
then checked for multicollinearity and tested for goodness of fit with the receiver operating 
characteristic (ROC) curve. We calculated the mean residuals per MS region and checked the 




The nesting of all individuals within MS regions implied a hierarchical data structure. In order 
to take this into account, we additionally performed multilevel logistic regression (multilevel 
model 1) with patients as the 1st level and MS regions as the 2nd level. Besides, we also 
considered the hospitals where surgeries were performed as a random effect in multilevel 
modeling. However, the 3-level data structure (patient – hospital – MS region of residence) was 
not entirely hierarchical, namely not all patients residing in one MS region had surgeries in 
hospitals within the same MS region. To solve this cross-classification issue, we further built a 
cross-classified multilevel model (multilevel model 2) taking both MS regions and hospitals 
into consideration as random effects. As the cluster-level covariate in multilevel model 2, the 
effect of hospital type was quantified using the 80% interval odds ratio (IOR-80) [21-23]. This 
decision was taken because other than individual-level covariates in multilevel models, cluster-
level covariates take only one value in each cluster. The interpretation of standard odds ratios 
is hence not straightforward for cluster-level covariates. Considering the distribution of odds 
ratios comparing two patients with different cluster-level covariate values (having surgeries in 
hospitals of a different type), but identical values for all other covariates, the IOR-80 covers the 
middle 80% of such odds ratios and has been recommended to describe cluster-level 
associations. The IOR-80 is narrow if between-cluster variation is small, and vice versa. If IOR-
80 contains the value of one, the between-cluster variation is more important than the effect of 
the cluster-level covariate, if not, the latter is more relevant. To estimate the degree of the 
random variation, we calculated the median odds ratio (MOR) for both multilevel models. The 
MOR compares the adjusted odds of POCR utilization in two patients with the same covariates 
except residing in two randomly selected MS regions (or having surgery by two randomly 
selected hospitals), and it can be interpreted as the median of these ORs. MOR is always above 
or equal to one since it is the median odds ratio between the person with a higher propensity 
and the person with a lower propensity for the outcome of interest [21-23]. MOR could be used 
directly for comparison with ORs of fixed-effect variables [21-23]. We then drew caterpillar 
plots of higher-level residuals to identify the MS regions that were significantly different from 
the average of all MS regions. At last, we checked spatial correlation of the two multilevel 
models’ residuals at MS region level using Moran’s I statistic. Due to the multilevel nature of 
data and the potential effect of MS region and hospitals on POCR utilization, we regarded the 
cross-classified multilevel regression model as our main model. To justify the random effects, 
we also calculated the variation partition coefficient (VPC) for both the MS region and hospital 






In total, 47,215 insured patients who experienced hospitalization for non-emergency surgery 
were analyzed in our study. Among them, 6,121 (13.0%) had ambulatory chest radiography 
within two months before surgery. Table 1 shows the characteristics of all included patients, 
patients with POCR, and patients without POCR, respectively. Women accounted for 57.4% of 
the total study population, and the mean age was 60.3 years. Compared to patients without 
POCR, patients with POCR were older (mean age: 68.4 vs. 59.1 years old), more frequently 
male and wealthier. They also preferred mandatory plus additional health insurance, high 
franchise, standard insurance model and supplementary hospital care insurance; and they were 
more likely to have an intrathoracic pathology and multi-morbidity; finally, they more often 
had surgery in a primary hospital or surgical hospital. 
POCR raw rates varied from 2.5% to 44.4% across 106 MS regions (the range was 2.3% to 
30.7% after age standardization). Geographic distribution of POCR utilization across MS 
regions is shown in Figure 1. There were considerable geographic variation and clustering of 
POCR rates. Geographic distribution of all considered influencing factors are shown in 
Supplementary Figure S1 online. Moran’s I value of POCR raw rates across MS regions was 
0.26 and was statistically significant (p<0.001). It indicates substantial spatial autocorrelation 
in POCR utilization, namely the POCR use is not randomly distributed among MS regions, and 
the POCR rate of one region is more similar to its neighbouring regions compared to regions 
far away. Figure 2 presents a LISA cluster map of POCR raw rates with several significant 
clusters of POCR utilization across Switzerland. The main high-high spatial cluster (regions 
with high POCR rates surrounded by neighbours also with high rates) was detected around the 
canton of Fribourg. The Moran’s I statistic and LISA clustering maps of possible influencing 












Table 1. Characteristics of 47215 insured patients undergoing inpatient surgery during the 
year 2013 to 2015. 
Characteristics Total Without POCR With POCR 
n 47215 41094 (87.0%) 6121 (13.0%) 
Female 27086 (57.4%) 23829 (58.0%) 3257 (53.2%) 
Age (mean, SD) 60.3 (17.2) 59.1 (17.4) 68.4 (12.6) 
Purchasing power index per household 101.7 (22.7) 101.6 (22.4) 102.8 (24.3) 
Urban residence  36457 (77.2%) 31783 (77.3%) 4674 (76.4%) 
Language region    
German 37547 (79.5%) 32615 (79.4%) 4932 (80.6%) 
French 6157 (13.0%) 5457 (13.3%) 700 (11.4%) 
Italian 3511 (7.4%) 3022 (7.4%) 489 (8.0%) 
Intrathoracic pathology indicationa 24566 (52.0%) 20479 (49.8%) 4087 (66.8%) 
Multi-morbidityb 26267 (55.6%) 22056 (53.7%) 4211 (68.8%) 
Insurance coverage    
Mandatory 10875 (23.0%) 9674 (23.5%) 1228 (20.1%) 
Mandatory and supplementary 36340 (77.0%) 31447 (76.5%) 4893 (79.9%) 
Supplementary hospital care insurance 11858 (25.1%) 10153 (24.7%) 1705 (27.9%) 
High franchise (>500 Swiss Francs) 7799 (16.5%) 7163 (17.4%) 636 (10.4%) 
Mandatory insurance models    
Standard 24108 (51.1%) 20742 (50.5%) 3366 (55.0%) 
Managed care 23107 (48.9%) 20352 (49.5%) 2755 (45.0%) 
Type of hospital performing surgeryc    
Central hospital 19711 (41.7%) 17511 (42.6%) 2200 (35.9%) 
Primary hospital 21269 (45.0%) 18298 (44.5%) 2971 (48.5%) 
Surgical hospital 5130 (10.9%) 4317 (10.5%) 813 (13.3%) 
Other specialized clinic 1105 (2.3%) 968 (2.4%) 137 (2.2%) 
 POCR: preoperative chest radiography; SD: standard deviation; a. Patients with either 
cardiovascular disease or respiratory disease based on pharmaceutical cost groups (PCG); b. 
Patients with two or more than two chronic diseases based on PCG; c. Categorized according 














In the logistic regression model (Table 2), higher age, indication of intrathoracic pathology, 
multi-morbidity, higher purchasing power index per household, and receiving surgery in 
hospitals providing lower levels of care (i.e., primary hospitals, surgical hospitals and other 
specialized clinics) were positively associated with the use of POCR. In contrast, female 
gender, urban residence, living in the French-speaking compared to German-speaking region, 
choice of an insurance model with high deductibles and supplementary hospital care insurance 
showed a negative association. We did not find multi-collinearity and the area under ROC curve 
(AUC) was 0.67. There was no significant effect modification identified in the model. Moran’s 
I of mean model residuals per MS region was 0.28 (p<0.01), indicating the presence of residual 
spatial correlation remained after the modeling of covariate effects. Therefore, the model 
assumption of independent residuals was not perfectly met and the model needs to be improved 
further. 
Indicators of purchasing power index per household, urban residence, and language region were 
not significant and therefore excluded from both multilevel models (Table 2). The effect of 
hospital type on POCR utilization in multilevel model 1 was remarkable, with odds ratios of 
1.37 (95% CI: 1.28-1.46) for primary hospital, 1.62 (95% CI: 1.48-1.78) for surgical hospitals 
and 1.29 (95% CI: 1.06-1.57) for other specialized clinics compared to central hospitals. In 
multilevel model 2, only the category of surgical hospitals had a significant OR of 1.44 (95% 
CI: 1.04-1.99) compared to central hospitals, while the joint p-value for the overall hospital 
type variable was 0.137. Consistent with that, the IOR-80 for each hospital type compared to 
central hospitals was relatively wide and contained the value of one, reflecting substantial 
unexplained variation between hospitals and implying that hospital type did not account for 
much of this heterogeneity. The median odds ratio (MOR) of MS region in multilevel model 1 
was 1.49, suggesting a large amount of variation between MS regions. In multilevel model 2, 
the MOR of MS region (MORMS) decreased to 1.25, indicating only moderate heterogeneity 
between MS regions, while the MOR of hospital was higher (MORHP=1.69), suggesting a large 
amount of variation between hospitals, which was also reflected in the wide IOR-80. From the 
caterpillar plot of multilevel model 2, we identified 11 MS regions significantly differing from 
the average MS region random effect. Among them, 5 MS regions had a significantly lower 
probability of performing POCR compared to the average probability (one MS region in canton 
Zurich, one in canton Bern, one in canton Valais and two in canton Solothurn), and 6 had a 
significantly higher probability (one in canton Zurich, one in canton Fribourg, one in canton 
Aargau, one in canton Ticino and two in canton Bern). Figure 3 shows the geographic locations 








Figure 3. MS regions significantly different from the average MS region effect identified from 
caterpillar plot of the cross-classified multilevel model. 
 
 
The Moran’s I of multilevel model 1 residuals at MS region level was 0.34 (p<0.01). However, 
after taking hospital into consideration as random effect, multilevel model 2 residuals at MS 
region level showed little spatial correlation (Moran’s I = 0.066, p=0.115), implying that the 
model assumption was met and cross-classified multilevel model solved spatial correlation 
issue well. The VPCs for the MS region and hospital levels were 1.6% and 8%, respectively. 
 
Discussion 
We found substantial variation in POCR utilization rates across 106 MS regions in Switzerland. 
Different factors including patient socio-demographic and clinical characteristics, health 
insurance features, and hospital-related factors appeared to affect POCR utilization. Moderate 
variation of POCR utilization across MS regions and especially hospitals persisted after the 
adjustment for these factors, hinting at the existence of additional influences not covered by our 
dataset. 
Due to very limited clinical and economic benefit of POCR in asymptomatic patients, both the 
US Choosing Wisely initiative and Smarter Medicine in Switzerland have put POCR on their 




US showed a prevalence of 91.5% for POCR among patients with unremarkable history and 
physical examination results in 2013 [24]. Another US study using 2009 Medicare claims data 
showed a 5.5% POCR utilization rate [25]. Two studies in Canada examined hospital databases 
from 2005 to 2007 and 2008 to 2013, and reported 23.3% and 10.8% POCR utilization rates in 
Alberta and Ontario, respectively [13, 26]. Overall POCR rate in our study was 13.0%, which 
did not differ much from the previous findings except the one for the US with a 91.5% POCR 
rate (for which we have not found an obvious explanation). However, these results may not be 
entirely comparable because of different sample selection and outcome definition. For example, 
there were differences regarding the databases used (health insurance claims data, further 
healthcare administrative data or hospital discharge data), the age ranges of the study 
populations (patients above 18 years or only the elderly patients), the surgery types included 
(inpatient vs. outpatient surgeries, low risk surgeries, elective surgeries, or non-cardiothoracic 
surgeries), and the time period before surgery (“preoperative” was defined inconsistently as 14, 
30 or 60 days before surgery in different studies). In our study, we considered POCR performed 
within two months before any inpatient surgeries in all patients, without excluding 
cardiothoracic surgeries or patients with cardiopulmonary diseases. Therefore, a certain degree 
of POCR utilization was expected and would be justified in the present study.  
The first study investigating the geographic variation of POCR utilization in Switzerland so far, 
by Blozik et al., demonstrated a substantial variation of POCR rates at the cantonal level. Across 
the 26 Swiss cantons, the observed minimum was 6% in the canton of Obwalden and the 
maximum 28% in the canton of Schwyz [10]. When using smaller geographic units – MS 
regions in our study, we observed considerable small area variation (raw rate of POCR 
utilization rate across MS regions: 2.5% to 44.4%), also within cantons. The three MS regions 
with the highest POCR rates were in cantons of Valais and Fribourg, and the three with the 
lowest POCR rates were in cantons of St. Gallen, Valais and Graubünden.  
Our cross-classified multilevel results suggested that the most relevant factors of POCR 
utilization available in our claims data were older age, male gender, indication of intrathoracic 
pathology, choice of an insurance model with low deductibles, having supplementary hospital 
insurance, and multi-morbidity. Older patients generally have worse health status and more 
comorbidities, thus they tend to be treated with more caution; the same applies to patients with 
multi-morbidity. Lower use of POCR in women may be partly related to different types of 
surgery performed on men and women; this possibility could be further explored with detailed 




receive POCR, not unexpected for patients with an intrathoracic pathology. The health 
insurance related factors indicated that patients choosing a higher franchise had a lower 
probability of POCR. One reason may be that patients choosing a higher franchise are normally 
healthier, besides, higher out-of-pocket costs could make them more reluctant to undergo 
POCR. Patients with supplementary hospital care insurance had a slightly lower probability of 
POCR. This finding might be due to patients’ selection of “better” or “more expensive” care 
such as ultrasound or MRI, compared to POCR. However, we expect inpatient POCR to be 
generally rare (see below). There have been few other studies investigating possible influencing 
factors of POCR utilization. One US study [13] found that older age, certain comorbidities and 
preoperative consultations played an important role. Our finding of an impact of health 
insurance-related factors as an example of non-clinical patient-sided factors on POCR is 
relatively novel. 
The MORMS in multilevel model 2 implies that moderate unexplained variation of POCR 
utilization across MS regions persisted after controlling for the available influencing factors. 
Based on both the wide IOR-80 of hospital type and the relatively high MORHP value in 
multilevel model 2, the between hospital variation of POCR utilization was substantial and 
cannot be explained by hospital type. Hospitals made a more relevant contribution than MS 
regions to the variation of POCR utilization. Similarly, Blozik et al. also observed large 
variance between hospitals within a canton, and concluded that individual hospitals proceed 
very differently with the placement of the POCR [10]. The residual between-MS region and 
between-hospital variation after modeling might be due to certain regional or hospital-level 
determinants that we could not control for in our study, for instance, provider density, attitude 
of physicians or patients, acceptance of guidelines. Although there was very few literature 
studying impact factors of POCR variation, some studies exploring factors influencing 
utilization of other health services might give us some insight into possible neglected predictors. 
For example, Chen I et al. concluded that neighbourhood education could affect hysterectomy 
utilization rate[27]. Another study found that primary care use was influenced by the density of 
primary care practices[28]. They might be included in further studies. In addition, the 
underlying mechanisms that account for the 11 MS regions being significantly different from 
the average effect should also be further investigated closely and locally for better health service 
provision and resource allocation. Most previous studies [29-31] only conducted descriptive 
assessments of regional variations of healthcare utilization, reporting, for example, interquartile 
range, extremal quotient (EQ), coefficient of variance (CV) and systematic component of 




highlighted a more advanced and comprehensive method of regional variation estimation 
through multilevel modelling, which we will transfer and apply to studies planned for other 
healthcare services of interest. 
The present study was based on claims data before the “Smarter Medicine” initiative was 
introduced in Switzerland in 2016. A possible follow-up study might provide additional insights 
into the influence of negative recommendation on POCR utilization. The study had a few 
limitations. First, due to the limitation of health insurance claims data some potentially 
important variables such as whether or not there was an indication for POCR, the physicians’ 
and patients’ preferences, etc. were lacking. Also, our data on POCR utilization were based on 
claims data from the outpatient sector. We had no details of services, treatments or procedures 
during inpatient episodes. POCR use during inpatient stays would not have been captured. 
However, due to financial incentives encouraging the transfer of diagnostic measures to before 
inpatient stays, we assume that inpatient POCR occurred relatively rarely [10]. We did not have 
information on where the outpatient POCR were performed, but we do not consider this as very 
relevant for the decision for or against POCR use. Furthermore, the results came from a single 
health insurance company in Switzerland. Enrolees of other Swiss health insurers might 
theoretically show different patterns of use. However, the results presented here were based on 
an insured population of 1.2 million people from all regions of Switzerland. Helsana internal 
data show no evidence of deviation in basic characteristics of its own customers compared to 
the whole population. The benefit package of the obligatory health insurance is defined at the 
federal level and the same for all health insurance companies, and all physicians collaborate 
with all insurance providers. Thus we assume no huge difference between our study population 
from Helsana and whole Swiss population. Even if the Helsana population is not perfectly 
representative of whole population, we believe it has no big impact on the association results 
in our study.  The results should be generalizable to a large extent for the whole Switzerland. 
In addition, theoretically, there might have been a surgery because of the chest radiography 
which we were not able to identify, although we believe the proportion of such situation would 
be quite small. 
In conclusion, our study observed substantial variation of POCR utilization across MS regions 
in Switzerland. Patients’ socio-demographics and clinical characteristics, choice of health 
insurance, and hospital-related factors influenced POCR utilization. Despite controlling for 
these influencing factors, variation across MS regions and especially across hospitals persisted, 
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Exploring geographic variation of and influencing factors for 
utilization of four diabetes management measures in Swiss 
population using claims data 
 
This chapter is based on the second article 





















Four strongly recommended diabetes management measures are biannual glycated 
haemoglobin (HbA1c) testing, annual eye examination, kidney function examination, and low-
density lipoprotein (LDL) testing in patients below 75 years. We aimed to describe regional 
variation in the utilization of the four measures across small regions in Switzerland and to 
explore potential influencing factors.  
Research Design and Methods 
We conducted a cross-sectional study of adult patients with drug-treated diabetes in 2014 using 
claims data. Four binary outcomes represented adherence to the recommendations. Possible 
influencing factors included socio-demographics, health insurance preferences and clinical 
characteristics. We performed multilevel modelling with Medstat regions as the higher level. 
We calculated the median odds ratio (MOR), and checked spatial autocorrelation in region level 
residuals using Moran’s I statistic. When significant, we further conducted spatial multilevel 
modelling.  
Results 
Of 49,198 diabetes patients (33,957 below 75 years), 69.6% had biannual HbA1c testing, 44.3% 
each had annual eye examination and kidney function examination, and 55.5% of the patients 
below 75 years had annual LDL testing. The effects of health insurance preferences were 
substantial and consistent. Having any supplementary insurance (odds ratios (OR) across 
measures were between 1.08 and 1.28), having supplementary hospital care insurance (1.08-
1.30), having chosen a lower deductible level (e.g. CHF 2500 compared to CHF 300: 0.57-
0.69), and having chosen a managed care model (1.04-1.17), were positively associated with 
recommendations adherence. The MORs (1.27-1.33) showed only moderate unexplained 
variation, and we observed inconsistent spatial patterns of unexplained variation across the four 
measures. 
Conclusion 
Our findings indicate that the uptake of strongly recommended measures in diabetes 
management could possibly be optimized by providing further incentives to patients and care 
providers through insurance scheme design. The absence of marked regional variation implies 
limited potential for improvement by targeted regional intervention, while provider-specific 




Significance of the study 
What is already known about this subject? 
 Better adherence to clinical guidelines and recommendations could increase clinical 
outcomes of diabetes patients.  
 Little is known about the utilization and its regional variation of recommended measures 
in diabetes management.  
What are new findings? 
 In a healthcare system with mandatory health insurance, choosing a lower deductible 
level, choosing a managed care model and having supplementary insurance were 
associated with better adherence. 
 Unexplained variation after adjusting for possible influencing factors was not 
pronounced, and inconsistent spatial patterns were observed across different measures.  
How might these results change the focus of research or clinical practice? 
 The findings imply a potential to optimize the utilization of recommended healthcare 




















Diabetes is one of the most common chronic diseases. The global prevalence in adults over 18 
years was 8.5% (around 422 million) in 2014, and deaths directly caused by diabetes were 
estimated at 1.6 million in 2016[1]. In Switzerland, an estimated 500,000 persons suffer from 
the condition, which is responsible for around 2% of all deaths [2]. Diabetes can be treated and 
its complications delayed through various measures, including constant medical care, restricted 
diet, physical activity and regular screening [3].  
A variety of clinical guidelines on diabetes management have been developed nationally and 
internationally to improve outcomes. The Swiss Society of Endocrinology and Diabetology 
(SGED) has developed “The criteria for good disease management of Diabetes in primary care” 
in 2013 and revised it in 2017[4]. The American Diabetes Associations, the European Society 
of Cardiology, and the European Association for the Study of Diabetes report and annually 
adapt clinical guidelines on diabetes as well [5, 6]. Some recommendations on diabetes 
management are crucial and consistently present in almost all clinical guidelines, for instance, 
biannual glycated haemoglobin (HbA1c) testing, annual eye examination and low-density 
lipoprotein (LDL) testing. Studies have shown strong evidence that the complications of 
diabetes could be reduced through managing risk factors such as increased HbA1c, low-density 
lipoproteins (LDL), and blood pressure [7-9]. It has also been reported that adherence to clinical 
guidelines had a positive influence on clinical outcomes including mortality and 
hospitalizations [10-12]. 
In the present study, we used four strong standard recommendations included in most diabetes 
clinical guidelines, that is, diabetes patients should undergo 1) at least two HbA1c tests per 
year, 2) at least one eye examination per year, 3) at least one kidney function examination per 
year, and 4) at least one LDL test per year (only in patients below 75 years). One study in 
Switzerland using health insurance claims data for the years 2011-2013 reported overall 
adherence to these recommendations but did not perform an in-depth assessment of drivers of 
utilization or geographic variation [13]. Generally, few studies have investigated the adherence 
to clinical recommendations on diabetes management. 
Various factors may affect the utilization of healthcare services for diabetes, including 
characteristics of patients, healthcare providers, health insurance, and regions. This could result 
in geographic variation in utilization. Such variation in utilization may be unwarranted, which 




and based on high-quality evidence, and the corresponding management measures are not 
preference-sensitive [15]. Moreover, access to healthcare in general and the four measures in 
particular is very good in Switzerland. Therefore, we expected little unexplained variation after 
adjusting for possible influencing factors in the present case [16].  
The aims of this study were to a) investigate the utilization levels of the above-defined strongly 
recommended measure in diabetes management, b) explore potential factors influencing 
utilization, and c) assess the regional variation in utilization of the four measures across small 
regions in Switzerland. 
 
MATERIALS AND METHODS 
Study population 
We used health insurance claims data provided by the Helsana Group, one of the largest health 
insurance companies in Switzerland. The Helsana database underlying this study included 
mandatory health insurance claims from around 1.2 million people, covering 15% of the Swiss 
population. Adults (older than 18 years) enrolled with Helsana who were prescribed any 
diabetes medication (the Anatomical Therapeutic Chemical (ATC) code was used to identify 
diabetes medications) between 1st January 2014 and 27th December 2014 were analysed. We 
excluded enrolees with incomplete insurance coverage in 2014 or not surviving until the end of 
2014, patients living outside Switzerland, asylum seekers, Helsana employees, patients with 
incomplete address information, and patients living in nursing homes with lump-sum 
reimbursement. Since diagnosis information was not available for outpatient services, we could 
not distinguish between type 1 and type 2 diabetes. 
Basic health insurance (covering a federally defined benefit package) is mandatory in 
Switzerland and private insurance companies are obliged to offer it to anyone irrespective of 
their health status. Mandatory health insurance includes appropriate and cost-effective in- and 
outpatient health services. A variety of annual deductibles (300 - 2,500 Swiss Francs(CHF)) 
can be chosen, and selecting a higher deductible leads to a lower premium. Enrolees can also 
choose between standard and managed care models, where the latter require a specific general 
practitioner or telemedicine provider as the first contact when a new health problem arises, 




supplementary health insurance products can be bought, for instance, supplementary hospital 
care insurance which allows for hospitalization in semiprivate/private wards [17]. 
Outcome and explanatory variables 
We differentiated the participants according to whether they received diabetes medication 
between 5th January 2013 and 31th December 2013 (prevalent cases if they received it, incident 
cases if they did not). The date of the first prescription of any diabetes medication in 2014 
(incident cases) or 1st January 2014 (prevalent cases) was considered as the index date for each 
participant. The following 360 days were regarded as the assessment period, which was used 
to define if the recommendations were being adhered to.  
We defined binary outcome variables for the four measures under study: in the assessment 
period, a) at least two HbA1c tests, b) at least one eye examination (ophthalmologist visit was 
used as a proxy of eye examination), c) at least one kidney function examination (i.e. serum 
creatinine and/or albuminuria test), and d) at least one LDL test (or total cholesterol + high-
density lipoprotein (HDL) + triglycerides test) for patients below 75 years [19]. 
The explanatory variables included a) socio-demographics, including age, gender, language 
region, purchasing power index per household, and urban/rural residence, b) health insurance 
preferences, including having both mandatory and supplementary insurance, having 
supplementary hospital care insurance, standard or managed care model, choice of annual 
deductible, and c) clinical characteristics, including number of comorbidities (pharmaceutical 
cost groups (PCG) were used to deduce chronic morbidity based on drug use[20]) and incident 
or prevalent diabetes treated with oral medication or insulin. In addition, a region level variable 
- ophthalmologist density per 10,000 inhabitants - was used specifically for the study of eye 
examinations. 
Geographic unit     
We used Medstat regions as the geographic units for regional variation analysis. Medstat 
regions (N=705) are defined by the Swiss Federal Statistical Office to reflect hospital catchment 
areas in a way that they are large enough to provide anonymity for each person hospitalized in 
Switzerland [21]. Each patient’s residence was assigned to the corresponding Medstat region 





First, we performed a descriptive analysis of study population’s characteristics. We 
distinguished between all eligible patients and the subpopulation below 75 years, relevant for 
the assessment of LDL testing.  
Second, we mapped out the raw utilization rates of the four measures across Medstat regions to 
show their geographic distribution. We checked spatial autocorrelation of regional utilization 
rates by computing the global Moran’s I statistic [22]. Moran’s I measures the correlation of a 
variable with itself through space, with a value range from -1 to 1. Moran’s I values very close 
to 0 suggest the studied variable is randomly distributed through space. If Moran’s I is positive 
with p<0.05, it indicates that neighbouring regions are more similar than distant regions, and 
the vice versa if Moran’s I is negative with p<0.05. 
Third, we performed multilevel multivariable logistic regression for each measure, with 
patients as the lower-level units and Medstat regions as the higher-level units. Decisions on 
inclusion of explanatory variables were based on the deviance information criterion (DIC) [23]. 
We included age as a quadratic term to allow for non-linear relationships. The Medstat region-
level variable of ophthalmologist density per 10,000 inhabitants was included in the model for 
eye examination. To estimate the degree of random variation in the multilevel models, we 
calculated the median odds ratio (MOR) at the Medstat region level. The MOR compares the 
adjusted odds of being adherent to the recommendation in two patients with identical 
characteristics, but living in two randomly selected Medstat regions. It is defined as the median 
of all possible, resulting odds ratios (ORs). The MOR is never below one as the comparison is 
always between the higher-propensity region and the lower-propensity region, for the outcome 
of interest [24-26]. A higher MOR indicates a higher level of unexplained variation in 
utilization after multivariable adjustment, and it can be compared directly with the ORs of the 
fixed effects [24-26]. We then checked for the presence of spatial autocorrelation in the model 
residuals at the Medstat region level, for each measure [22]. 
Finally, in cases with significant spatial autocorrelation present in the multilevel model 
residuals, we further developed Bayesian hierarchical logistic regression models capturing 
spatial variation at the Medstat region level through the Integrated Nested Laplace 
Approximations (INLA) approach [27-30]. This was performed with the R-INLA package [31]. 
The covariates included in the spatial multilevel models were the same as in the multilevel 
multivariable models above. The marginal effects of age divided into 50 groups were inspected 
graphically, which was more intuitive than reporting regression coefficients. The finally 




Statistical analyses were performed using R 3.4.4 [32], STATA 13, and MLwiN 3.04 [33] 
integrated in STATA using the runmlwin package. Mapping was conducted with QGIS 1.14.16 
[34], and spatial clustering analysis was done with GeoDa 1.10 [35]. 
 
RESULTS 
A total of 49,198 diabetes patients were analysed in this study. The mean age was 66.6 years, 
and women accounted for 45.0% of the whole study sample. Overall, 34,254 (69.6%) patients 
had at least two HbA1c tests in their assessment period, 21,808 (44.3%) patients had at least 
one kidney function examination, and 21,804 (44.3%) patients had at least one eye examination. 
Among the 49,198 diabetes patients, 33,957 were below 75 years and were analysed for LDL 
testing. In this subpopulation, 18,851 (55.5%) patients had at least one LDL test in the 
assessment period. The mean age was 60.1 years, and 41.2% were women. Table 1 shows the 
socio-demographics, health insurance preferences and clinical characteristics of the total 
population and of the below 75 years, respectively.  
The ORs and 95% confidence/credible intervals (95%CIs) of all explanatory variables (except 
age, shown in Figure 1) in both the multilevel multivariable models and the spatial multilevel 
models are shown in Figure 2 (full numerical details are available from supplementary table S1 
and S2). For each pair of models representing one outcome, covariate effects were similar, 
except for language region. Regarding socio-demographics, women were more likely to follow 
the recommendations of eye examination and kidney function examination, while the opposite 
was true for LDL testing. Purchasing power index was positively associated with eye 
examination and kidney function examination, while it was negatively associated with HbA1c 
testing. Living in an urban area had a positive association with kidney function examination 
and LDL testing. Compared to the German speaking area, living in the French or Italian 
speaking area of Switzerland demonstrated a negative association with HbA1c testing and eye 
examination, as well as positive associations with LDL testing and kidney function 
examination. As expected, these associations were strongly attenuated in the spatial multilevel 
models. The effects of health insurance preferences and clinical characteristics were mostly 
consistent across the four measures. Having any supplementary insurance (odds ratios across 
measures were between 1.08 and 1.28), having supplementary hospital care insurance (1.08-
1.30), having chosen a managed care insurance model (1.04-1.17), and having more 
comorbidities (e.g. having more than two morbidities compared to none: 1.25-1.57), were all 




deductible level had a negative association with being adherent to the recommendations (e.g. 
CHF 2500 compared to CHF 300: 0.57-0.69). Prevalent cases receiving insulin compared to 
incident cases had a positive association with HbA1c testing, eye examination and kidney 
function examination, while having a negative association with LDL testing. A positive 
association between ophthalmologist density and eye examination was found in both models of 











   
Figure 1. Age effect in spatial multilevel models.  
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OR:  odds ratio; CI: confidence/credible interval; HbA1c: glycated hemoglobin; LDL: low-density 
lipoprotein; CHF: Swiss franc; Pchp: purchasing power; mdt: mandatory insurance; sup: 
supplementary insurance; std: standard; mc: managed care; Suph insurance: supplementary hospital 
insurance; Oph: ophthalmologist; Multimorbidity: pharmaceutical cost groups (PCG) were used to 
deduce chronic morbidity based on drug use. 
 
The geographic distribution of the utilization of the four measures across Medstat regions is 
shown in Figure 3. By visually inspecting the maps, we noted considerable geographic variation 
for each measure, with quite different spatial patterns. For HbA1c testing, utilization rates were 
generally higher in the German-speaking north and middle part of Switzerland, while there was 
no such pattern visible for the other three measures. Positive and statistically significant 
(p<0.05) Moran’s I values of the raw rates indicating the presence of spatial autocorrelation 
were 0.46 for HbA1c testing, 0.27 for eye examination, 0.21 for kidney function examination, 
and 0.35 for LDL testing. After multilevel multivariable model adjustment, Moran’s I values 
of the residuals at the Medstat region level decreased to 0.12 (p<0.0001) for HbA1c testing, 
0.13 (p=0.0001) for kidney function examination, and 0.07 (p=0.004) for LDL testing.  Only 
for eye examination, we found a slight increase of spatial autocorrelation to 0.30 (p<0.001) 
after model adjustments. In consequence, we regarded the spatial multilevel models as most 
appropriate, because they accounted for the spatial structure in the data. The MORs in the 
multilevel multivariable models, describing variation between Medstat regions, were 1.28 for 
HbA1c testing, 1.31 for eye examination, 1.27 for kidney function examination, and 1.33 for 
LDL testing.  
The unexplained spatial variation remaining after multivariable adjustment through spatial 
multilevel models for each measure is shown in Figure 4. The OR values in the Figure 4 
represent the odds of being adherent to the recommendation in one specific Medstat region 
compared to the average odds in the whole of Switzerland. We observed spatial clusters of 
better adherence in the northeast and middle parts of the country for HbA1c testing, in the north 
and east parts for eye examination, in the southwest and southeast parts for kidney function 




   








   
Figure 4. Unexplained variation in the utilization of four diabetes management measures in spatial multilevel models (Odds ratio values 
represent the odds of being adherent to the recommendation in one specific region compared to the average odds in the whole of 
Switzerland). 
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Observed utilization rates in 2014 in Switzerland of four strongly recommended measures in 
diabetes management were 69.6% for biannual HbA1c testing, 44.3% for annual eye 
examination, 44.3% for annual kidney function examination, and 55.5% for annual LDL testing 
(in patients below 75 years). Associations between health insurance preferences and utilization 
were consistent across the four measures. Having supplementary insurance, choosing a lower 
deductible level, and choosing a managed care insurance model, were positively associated with 
being adherent to the recommendations. After adjusting for all available influencing factors and 
spatial autocorrelation, the unexplained regional variation was only moderate. There was no 
common pattern of spatial clustering visible across the four studied measures. 
The observed utilization rates suggest that the underlying recommendations were not being 
followed perfectly. In a previous study using year 2011 to 2013 data from the same data source, 
similar utilization rates were reported: 70.0% of patients had biannual HbA1c testing, 44.2% 
an annual eye examination, 12% both serum creatinine and albuminuria testing annually, and 
59.0% an annual lipid profile (total cholesterol, HDL and LDL, and triglycerides) [13]. The 
much higher rate of annual kidney function examination found in our study was mainly due to 
the use of a different definition of kidney function examination – a serum creatinine and/or 
albuminuria test.  
Overall, few studies assessing the utilization of management measures recommended for 
diabetes patients exist, and some with discrepant findings. Some studies from the US, Japan 
and Italy are directly comparable with ours as they reported on the utilization of at least one of 
our four measures of interest. For HbA1c testing, one study conducted in Texas, USA, reported 
a 54.8% biannual utilization rate [36], while the utilization rate in an Italian study was relatively 
low (33.9%) [37]. By contrast, a study from Japan using claims data found an annual utilization 
rate of 95.8% [38]. For eye examination, studies in the US reported utilization rates of 15.3% 
(using claims data) [39], 70% (using telephone survey data) [40], and 75% (data from rural 
Latinos) [41]. A Japanese study reported a utilization rate of 35.6% [38], and the rate in the 
Italian study was even lower (15.6%) [37]. The Italian study also reported a utilization rate of 
LDL testing of 52.1%, which was similar to the finding in our study [37]. However, these 
different reports may not be entirely comparable to our study since the data sources and 




Patients’ socio-demographics were associated with healthcare utilization. The probability of 
undergoing the four recommended measures was generally high between age 50 to 80 years, 
and decreased strongly thereafter. This was expected, because the elderly may have more 
barriers to accessing healthcare services due to poor health status. Moreover, the measures may 
become less important in the elderly as comorbidities and life expectancy affect priority setting 
and the benefit of preventing long-term complications. Women were more likely to undergo 
eye examination and kidney function examination in our study, which was consistent with 
previous findings [38, 42, 43]. However, women were less likely to undergo annual LDL 
testing, which might be due to more attention to the risk of cardiovascular disease in men. 
Myocardial infarction and related conditions have traditionally been perceived as 
predominantly male diseases. Living in an urban area was positively associated with more 
utilization of annual kidney function examination and LDL testing, which may be partly 
explained by easier access to healthcare facilities than in rural areas. The language region 
effects on the utilization of the four measures found in the present study indicated that the 
language region plays an important role in influencing healthcare utilization, which might be 
due to different culture and norms in each language region [44, 45].  
One of the key findings in the present study was the association between health insurance 
preferences and utilization of diabetes management measures, in a setting with mandatory 
insurance and universal access to care. Very few studies have explored the effect of health 
insurance-related factors on services utilization in diabetes patients. Most of the available 
studies only concluded that uninsured patients were less likely to use healthcare services than 
insured patients or patients with private insurance [36, 40]. While non-insurance does 
practically not occur in Switzerland, foregoing healthcare due to out-of-pocket payments is a 
well-documented phenomenon [46]. This is one of the first studies to look into potential 
influences of health insurance characteristics on utilization of measures on diabetes 
management in detail. Overall, we found consistent effects of health insurance characteristics 
on utilization across the four measures of interest, and they persisted after controlling for other 
important influences such as age, health status, and to some extent income (defined by regional 
purchasing power index). Patients with higher deductibles tend to be healthier and willing to 
take more risks, and some invoices may be missed in these patients, which may partially explain 
our observation of lower utilization of the measures of interest. However, higher out-of-pocket 
costs may also make patients more reluctant to use these measures, which would make high 
deductibles a financial barrier to recommended healthcare [47]. Similarly, patients having 




may tend to seek care more frequently and regularly, as observed in our study. Patients choosing 
a managed care model had more utilization of the measures studied than patients choosing an 
insurance model offering completely free physician choice. This finding is of great interest 
because it may indicate that strengthening a coordinative role of primary care physicians in 
managed care and providing financial incentives to the insured for choosing such models may 
also positively impact certain healthcare utilization indicators or outcomes. More health 
insurance incentives for participation in managed care models could be considered to achieve 
optimized healthcare utilization. 
Presence of comorbidities was associated with more utilization, which may be due to more 
health awareness, and regular contact with healthcare providers. The finding of the lower uptake 
of LDL testing among prevalent cases was unexpected, as we would have expected prevalent 
patients to be more adherent to disease management and treatment compared to new patients 
[48]. The ophthalmologist density covariate reflected the access to eye examination services, 
and thus partly explained the higher utilization of eye examinations in patients living in regions 
with more ophthalmologists. 
The unexplained geographic variation of utilization across small regions after adjusting for all 
available factors was only moderate for all four measures. One possible reason could be that 
we were unable to control for locally specific factors in our models. For example, physician-
level factors such as age, years in practice, the awareness of and attitude towards clinical 
guidelines and recommendations varies across physicians and could affect the communication 
with patients and finally the patients’ behaviours [49]. In addition, some patient level 
characteristics were not captured in our data source, e.g. educational level or marital status, as 
well as patients’ preferences, which were demonstrated to be potentially related to the 
utilization of healthcare services [40]. By mapping out the unexplained spatial variation, we 
noted that the spatial patterns of regional variation were inconsistent across the four measures 
studied. These patterns indicated that the utilization of the four measures strongly recommended 
to diabetes patients differ substantially within Switzerland. The spatial variation of utilization 
might be even less prominent after controlling for more potentially influential factors 
unmeasured in the present study, such as physician characteristics which could not be captured 
from the claims data. Combination of different data sources may serve as a promising approach 
in future studies.  
In addition to the limitations mentioned above, further potential weaknesses should be noted 




outpatient diagnoses are lacking. The study population was selected according to the 
prescription of any diabetes medication, which may have led to some misclassification of 
prevalent and incident cases, this might partially account for the unexpected finding of more 
utilization of LDL testing in incident patients. It was impossible to distinguish between type 1 
and type 2 diabetes. Patients with type 1 diabetes are a small fraction (approximately 8% in 
Switzerland in 2014[50]); they normally get the illness when they are young, tend to be well 
treated by specialists and are generally better at self-management. Due to the high costs of 
insulin injections and the associated medical supplies and devices, choosing a low deductible 
level is expected in type 1 diabetes patients. Such different behaviours may have had an impact 
on utilization of the four measures, and influenced our results to a certain degree. Besides, the 
laboratory tests results were not available from claims data and it was impossible to estimate 
the proportion of targets achieved for the diabetes management measures. Second, we used 
claims data from a single health insurer. Enrolees of other health insurers might theoretically 
have different characteristics and show different healthcare use patterns. However, the results 
presented were based on a population of 1.2 million covering all regions in Switzerland. The 
benefit package of the mandatory health insurance is defined at the federal level and is the same 
for all health insurers. Thus we expect little deviation of enrolees’ features compared to the 
total Swiss population, and the results should be generalizable to the whole of Switzerland.  
In conclusion, we observed that the utilization of four diabetes management measures was not 
optimal in Switzerland although these measures have been recommended broadly and are based 
on strong evidence. Socio-demographics, health insurance preferences and clinical 
characteristics were associated with their utilization. The presence of supplementary insurance, 
a lower deductible level and participation in a managed care plan were associated with higher 
utilization, consistently across the four measures. After controlling for available factors and 
spatial autocorrelation, maps of remaining variation indicated inconsistent patterns of 
utilization in the four measures. Our findings indicate that the uptake of strongly recommended 
measures for diabetes management could possibly be optimized by providing further incentives 
to insured and care providers through insurance scheme design. By contrast, due to the absence 
of marked regional variation patterns we conclude that there may be only limited potential for 
improvement by targeted regional intervention (e.g. awareness and promotion campaigns). 
Moreover, our novel approach aids in the identification of geographic variation and influencing 
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Table S2. ORs and 95%CIs of fixed effects in multilevel multivariable models and spatial 
multilevel models for LDL testing. 
OR: odds ratio; CI: confidence/credible interval; LDL: low-density lipoprotein; CHF: Swiss 
franc; Multimorbidity: pharmaceutical cost groups (PCG) were used to deduce chronic 





Characteristics Annual LDL testing 
multilevel model spatial multilevel model 
Female gender 0.90 (0.86, 0.94) 0.89 (0.85, 0.93) 
Urban residence 1.12 (1.06, 1.24) 1.12 (1.04, 1.21) 
Language    
German 1 1 
French 2.17 (1.98, 2.36) 1.69 (1.38, 2.07) 
Italian 1.42 (1.25, 1.61) 1.49 (1.01, 2.21) 
Deductible (CHF)   
300 1 1 
500 0.97 (0.92, 1.03) 0.97 (0.92, 1.03) 
1000 0.88 (0.76, 1.03) 0.88 (0.75, 1.03) 
1500 0.73 (0.63, 0.85) 0.74 (0.63, 0.86) 
2000 0.64 (0.41, 0.92) 0.63 (0.42, 0.94) 
2500 0.64 (0.54, 0.74) 0.64 (0.55, 0.75) 
Insurance coverage   
Only mandatory 1 1 
Mandatory and supplementary 1.12 (1.07, 1.18) 1.12 (1.06, 1.18) 
Mandatory insurance model   
Standard 1 1 
Managed care 1.09 (1.04, 1.14) 1.08 (1.03, 1.13) 
Supplementary hospital insurance 1.05 (0.98, 1.12) 1.04 (0.98, 1.11) 
Multimorbidity   
none 1 1 
1 1.16 (1.06, 1.26) 1.16 (1.07, 1.26) 
2 1.43 (1.32, 1.56) 1.44 (1.33, 1.57) 
>2 1.56 (1.43, 1.68) 1.57 (1.45, 1.70) 
Diabetes category   
Incident 1 1 
Oral drug only 0.92 (0.86, 0.99) 0.91 (0.84, 0.98) 
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Regional variation and effects of health insurance-related factors on 
the utilization of 24 diverse healthcare services  
 
This chapter is based on the third article 


























Objectives: We aimed to a) describe regional variation in the utilization of 24 diverse 
healthcare services in eligible populations in Switzerland, and b) identify potential influencing 
factors, especially health insurance-related characteristics, and explore the consistency of their 
effects across the selected services. 
Design and Setting: Cross-sectional population-based study in Switzerland using health 
insurance claims data for the year 2014. The studied healthcare services were predominantly 
outpatient, ranging from screening to secondary prevention. We performed a comprehensive 
methodological approach including small area variation analysis, spatial autocorrelation 
assessment, and multilevel modelling using 106 small regions as the higher level. 
Participants: For each selected service, the target population was identified based on 
applicable clinical recommendations. Individual-level information included socio-
demographics, clinical characteristics, health insurance-related characteristics, and resident 
region. 
Main outcome measure: For each service, the outcome variable was the use of the service by 
eligible individuals. The degree of adjusted variation in healthcare utilization was evaluated by 
median odds ratios (MORs). 
Results: Unadjusted utilization rates varied considerably across the 24 healthcare services, 
ranging from 3.5% (osteoporosis screening) to 76.1% (recommended thyroid disease screening 
sequence). The effects of health insurance-related characteristics were mostly consistent. A 
higher annual deductible level was mostly associated with lower utilization. Supplementary 
insurance, supplementary hospital insurance and having chosen a managed care model were 
associated with higher utilization of most services. Managed care models showed a tendency 
towards more recommended care. After adjusting for multiple influencing factors, the 
unexplained regional variation was generally small across the 24 services, with all MORs below 
1.5. 
Conclusions: The observed utilization rates seemed suboptimal for many of the selected 
services. For all of them, the unexplained regional variation was relatively small. Our findings 
confirmed the importance and consistency of effects of health insurance-related factors, 
indicating that healthcare utilization might be further optimized through adjustment of 






Section 1: What is already known on this topic 
 Large regional variation in the utilization of healthcare services exists 
 Healthcare utilization and regional variation may be driven by multiple factors 
Section 2: What this study adds 
 Across various healthcare services, utilization was substantially and consistently 
associated with health insurance-related characteristics, such as managed care versus 
standard fee-for-service care model, supplementary in addition to mandatory 
insurance, and annual deductibles 
 Residual regional variation in utilization after multivariable adjustment was small 





A recent systematic review found a substantial evidence base for large variation in the 
utilization of healthcare services across regions, hospitals, and healthcare providers [1]. The 
ubiquity and persistence of such variation cannot simply be explained by variation in the actual 
care needs of different populations [2]. A substantial portion may reflect inappropriate 
variability due to unequal access to care, potentially detrimental for quality of care and costs 
[3]. This unwarranted component, although difficult to quantify, should be minimized in order 
to improve the quality, equity, and efficiency of healthcare [4]. Regional variation may be 
driven by multiple factors, including patient socio-demographics, clinical characteristics, 
availability of physicians and healthcare facilities, and healthcare system-related factors [2]. 
They can function as personal, financial, and organizational modifiers of access to care [5]. 
System-related factors (e.g. relating to health insurance systems, national legislation or 
programs) are of strong interest, because their modification may offer big levers to reduce 
unwarranted variation at a national level. The credibility of related findings is stronger if effects 
are consistently observed across diverse healthcare services. 
Existing studies of regional variation in utilization mostly applied methods of small area 
variation analysis (SAVA) [1]. Several problems were identified. First, numerous analyses 
focused on only part of a country, without nationwide coverage. Second, the selection of studied 
healthcare services was often arbitrary and opportunity-driven, suggesting that future studies 
should focus on services of high clinical importance, policy relevance, and public awareness. 
Third, the causes and drivers of variation were rarely explored. Only few studies controlled for 
a limited number of possible influencing factors such as individual socio-demographics or 
clinical characteristics [6, 7]. Finally, most studies assessed the variation in utilization of a 
single service, or one category of services (e.g. related surgical procedures) [8, 9]. More 
comprehensive studies simultaneously comparing a wider range of services are currently 
missing. Around 40% of studies of variation in healthcare utilization used administrative data 
routinely collected for billing purposes. Although subject to certain limitations (e.g. restricted 
clinical information), health insurance claims data play an important role in health services 
research [10, 11].  
In the present study, we aimed to select a variety of healthcare services and their target 
populations based on applicable clinical recommendations, and to describe regional variation 




expenditures, using claims data. Specific goals were to a) evaluate unadjusted and adjusted 
regional variation in utilization in eligible populations, b) identify potential influencing factors, 
especially health insurance-related characteristics, and c) explore the consistency of these 
factors’ effects across the selected services.  
 
Methods 
Selection of healthcare services and eligible populations 
Our selection of healthcare services focused on primary healthcare for major non-
communicable diseases and was based on a systematic approach described earlier [12]. 
Recommendation statements from clinical practice guidelines of Swiss, European and relevant 
international medical societies, used in Switzerland, were considered pragmatically according 
to clinical relevance, expected frequency of service use, size of the eligible population, and 
feasibility to identify the population and service from Swiss health insurance claims data. Some 
services outside primary healthcare were included to extend the spectrum of populations 
investigated and reflect services currently debated in Switzerland. 
The final selection consisted of 24 services reflecting different categories of care, including 
screening (N=4), diagnosis (N=6), primary prevention (N=1), treatment (N=4) and secondary 
prevention (N=9). Table 1 lists their descriptions, eligible populations, and recommendation 
status. 
Study design and populations 
Our cross-sectional study used mandatory health insurance claims data provided by Helsana, 
one of the largest health insurers in Switzerland. The underlying database covered around 1.2 
million people, 15% of the Swiss population. The eligible population for each healthcare service 
was identified from persons enrolled with Helsana during 2014 (Table 1). Asylum seekers, 
Helsana employees, enrolees living outside Switzerland, with incomplete address information, 
















Swiss mandatory health insurance covers a federally defined, uniform benefit package for 
anyone living in Switzerland regardless of health status. A higher annual deductible (of Swiss 
Francs 500, 1000, 1500, or 2500) can be chosen instead of the legal minimum of 300, implying 
lower premiums. People can also choose between standard fee-for-service and managed care 
models [13, 14], the latter requiring a specific general practitioner or telemedicine provider as 
the first contact for a new health problem, and resulting in lower premiums. In addition to 
mandatory insurance, a variety of supplementary insurance products can be bought, for 
instance, supplementary hospital insurance allowing for hospitalization in semiprivate or 
private wards. 
The data provided by Helsana were anonymized. According to the national ethical and legal 
regulations, ethical approval was not needed for this type of analysis. This was confirmed by a 
waiver of the competent ethics committee (Kantonale Ethikkommission Zürich, dated 11th 
January 2017, BASEC-Nr. Req-2017-00011). 
Outcome and explanatory variables 
For each of the selected services, the outcome variable was whether the service was used by 
each member of the eligible population (Table 1). Candidate explanatory variables available 
for all 24 healthcare services included a) socio-demographics, i.e. age, gender, language region, 
purchasing power index, and urban/rural residence, b) health insurance-related characteristics, 
including having any supplementary insurance, having supplementary hospital insurance, 
choice of a standard or managed care model, choice of annual deductible, c) number of chronic 
comorbidities as indicated by pharmaceutical cost groups [15]. In people with supplementary 
hospital insurance, we could not distinguish the additional presence of other supplementary 
insurances but only evaluate a mixed effect. To verify the effect of supplementary hospital 
insurance, we performed sensitivity analyses using different combinations of available 
explanatory variables. We further included service-specific clinical conditions of relevance and 
a few service-specific non-individual level variables. For preoperative chest radiography 
(POCR), the type of hospital performing the surgery (central, primary, surgical, or other 
specialized hospital) was considered. For breast cancer screening, we determined if a cantonal-
level breast cancer screening program existed. Analysis of eye examinations in diabetes patients 
considered ophthalmologist density per 10,000 inhabitants in each region. For surgical 
procedures recommended to be performed in outpatient settings, hospital bed density per 1,000 





We used spatial mobility regions (mobilité spatiale - MS) as the geographic level of analysis 
(N=106). MS regions are defined by the Swiss Federal Statistical Office and used as 
intermediate-size units of analysis for scientific and regional policy purposes [16]. Each study 
participant’s residence was assigned to the corresponding MS region. 
Statistical analysis 
A four-step analytical approach was applied to all selected healthcare services. In the first step, 
we descriptively analysed each study population’s characteristics. 
Second, we calculated raw utilization rates per MS region and described the degree of regional 
variation using small area variation analysis (SAVA). We computed extremal quotient (EQ), 
interquartile range (IQR), coefficient of variation (CV) and systematic component of variation 
(SCV). SCV estimates the systematic component of variation between small regions by 
subtracting random from total variation, considering age and sex [8, 17]. SCV above 3, between 
5.4 and 10, and above 10 suggest relevant, considerable, and very high variation in utilization, 
respectively [18]. We further checked spatial autocorrelation of regional utilization rates with 
global Moran’s I statistic [19]. Moran’s I measures the correlation of a variable with itself 
across space, ranging from -1 to 1. Moran’s I close to 0 suggests random distribution across 
space. Significantly positive (negative) Moran’s I values indicate that neighbouring regions are 
more similar (dissimilar) than distant regions. 
Third, we performed two-level logistic regression modelling with individuals as the lower-level 
and MS regions as the higher-level of analysis. For POCR, a cross-classified model was 
developed, with hospitals where surgeries were performed as an additional level cross-
classified with MS regions, as we assumed an impact of hospitals on POCR utilization [20]. A 
sensitivity analysis used our standard, two-level approach. Inclusion of explanatory variables 
was based on the deviance information criterion [21]. We calculated multivariable-adjusted 
odds ratios (ORs) and 95% confidence intervals (95%CIs) to estimate the effect of explanatory 
variables on utilization. 
In the last step, we assessed the degree of unexplained regional variation after multilevel 
modelling by calculating median odds ratios (MORs) and variance partition coefficients 
(VPCs). MOR is extrapolated from the variance of random effects in multilevel models. It 




characteristics, but living in two randomly selected regions. The median of all possible resulting 
ORs is defined as MOR. MOR is always above one, as the higher-propensity region is always 
compared with the lower-propensity region for the outcome of interest. VPC represents the 
proportion of total variation accounted for systematic differences between MS regions. The 
interpretation of the magnitude of MOR should be related to VPC [22]. A relatively big MOR 
in combination with a considerable VPC indicates substantial regional variation [22]. In 
addition, we checked for spatial autocorrelation in model residuals across MS regions, again 
using global Moran’s I statistic [23, 24]. 
Statistical analyses were performed using R 3.4.4 [25], STATA 13, and MLwiN 3.04 [26] 
integrated in STATA using the runmlwin package [27]. Spatial autocorrelation analysis was 





Across the 24 selected healthcare services, eligible population size ranged from 409,960 for 
influenza vaccination to 1,992 for new prescription of a disease-modifying anti-rheumatic drug 
(DMARD) that should be prescribed concomitantly with a glucocorticoid (Table 2). The mean 
age of populations ranged from 31.9 years (women giving birth without absolute indications 
for C-section), to 80.8 years (patients with atrial fibrillation and indication for oral 
anticoagulation). Overall utilization varied from 3.5% of older people with risk factors for 
fractures receiving osteoporosis screening, to 76.1% of eligible people receiving a thyroid-








Effects of explanatory variables 
After multivariable adjustment, we observed inconsistent associations between socio-
demographic variables and healthcare utilization (Table S1). Age showed a nonlinear effect in 
most cases; utilization typically reached a peak between 50-70 years and then decreased (Figure 
S1). Gender effects were mostly not prominent. However, there was an OR of 3.66 (95%CI: 
3.10, 3.99) for osteoporosis screening use in women, while the OR for statin prescription in 
women with peripheral artery disease was 0.52 (95%CI: 0.49, 0.55). Having more 
comorbidities was significantly associated with increased use of most services, but not 
secondary prevention medication after acute myocardial infarction (AMI) or oral 
anticoagulation in patients with atrial fibrillation. 
The effects of health insurance-related characteristics were mostly consistent across the 24 
healthcare services. Having chosen a managed care model was significantly associated with 
increased use of most services in the categories of screening, diagnosis and secondary 
prevention, but decreased use of the four services in the treatment category (three of which 
were not recommended; the fourth were surgical procedures in the outpatient setting). The 
strongest effect was noted for C-section, with an OR of 0.81 (95%CI: 0.73, 0.91) (Figure 1). 
Having any supplementary insurance was associated with increased use of most services 
(Figure 2). A negative effect was again seen for C-section, with an OR of 0.86 (95%CI: 0.77, 
0.96). Having supplementary hospital insurance was also associated with increased use of most 
services, including C-section with an OR of 1.58 (95%CI: 1.37, 1.83). People with 
supplementary hospital insurance were also more likely to undergo surgical procedures with 
potential for being performed in the outpatient setting, as inpatients (Figure 3). Related 
sensitivity analyses showed consistent results. Having a higher deductible was associated with 
lower utilization of most healthcare services (Figure 4). All ORs and 95%CIs are shown in 
Table S1.  
Service-specific factors were associated with healthcare utilization. Patients having surgery in 
primary, surgical and other specialized hospitals were more likely to receive POCR than 
patients in central hospitals. Residing in a canton with a coordinated breast cancer screening 
program was associated with increased mammography utilization with an OR of 1.80 (95%CI: 
1.66, 1.97). Associations of ophthalmologist density with eye examinations in diabetes patients 
with an OR of 1.09 (95%CI: 0.93, 1.23) and of hospital bed density with having surgical 





Figure 1. Effects of managed care models on healthcare services utilization. 
 
*Indicates services that are discouraged and therefore an odds ratio <1 indicates better 
conformity with recommendations, for all other services, an odds ratio >1 indicates greater use 
and better guideline conformity. OR: odds ratio; CI: confidence interval; DM: diabetes mellitus; 
DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated haemoglobin; LDL: low-density 
lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest 
radiography; BZD: benzodiazepines; PPI: proton pump inhibitor; C-section: Caesarean section; 
AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-






Figure 2. Effects of supplementary insurance on healthcare services utilization. 
 
*Indicates services that are discouraged and therefore an odds ratio <1 indicates better 
conformity with recommendations, for all other services, an odds ratio >1 indicates greater use 
and better guideline conformity. OR: odds ratio; CI: confidence interval; DM: diabetes mellitus; 
DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated haemoglobin; LDL: low-density 
lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest 
radiography; BZD: benzodiazepines; PPI: proton pump inhibitor; C-section: Caesarean section; 
AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-





Figure 3. Effects of supplementary hospital insurance on healthcare services utilization. 
 
*Indicates services that are discouraged and therefore an odds ratio <1 indicates better 
conformity with recommendations, for all other services, an odds ratio >1 indicates greater use 
and better guideline conformity. OR: odds ratio; CI: confidence interval; DM: diabetes mellitus; 
DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated haemoglobin; LDL: low-density 
lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest 
radiography; BZD: benzodiazepines; PPI: proton pump inhibitor; C-section: Caesarean section; 
AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-






   
Figure 4. Effects of annual deductible level (Swiss Francs) on healthcare services utilization. 
 
OR: odds ratio; CI: confidence interval; DM: diabetes mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: glycated haemoglobin; LDL: low-density lipoprotein; 
TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest radiography; BZD: benzodiazepines; PPI: proton pump inhibitor; C-section: Caesarean section; 
AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: 




Unadjusted and adjusted regional variation 
Figure 5 illustrates the degree of unadjusted regional variation across 24 healthcare services; 
full numerical results are presented in Table S2. SCV indicated relevant variation for POCR 
(13.24), breast cancer screening (12.88), and long-term benzodiazepine use in older people 
(9.97).  
Figure 6 shows the degree of unexplained regional variation after controlling for the available 
influencing factors through multilevel modelling. MORs were below 1.5 for all services, and 
mostly below 1.3. VPCs for all 24 services were within 5.0%, and mostly below 2.0% (Table 
S2). MOR for POCR in the cross-classified model was 1.25 versus 1.46 in sensitivity analysis, 
suggesting that some variation among MS regions was accounted for by considering the 
hospital level. The combination of relatively small MORs and VPCs implied small unexplained 
variation for all 24 services. 
Multilevel model residuals for 10 healthcare services did not show spatial dependence across 




   
Figure 5. Degree of unadjusted regional variation across 24 selected healthcare services. 
 
 For some services, EQ and SCV are not applicable due to insufficient study population. DM: diabetes mellitus; DXA: Dual-energy x-ray absorptiometry; HbA1c: 
glycated haemoglobin; LDL: low-density lipoprotein; TSH: thyroid stimulating hormone; POCR: outpatient preoperative chest radiography; BZD: benzodiazepines; PPI: 
proton pump inhibitor; C-section: Caesarean section; AMI: acute myocardial infarction; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker; P2Y: 




Figure 6. Degree of adjusted regional variation across 24 selected healthcare services. 
 
MOR: median odds ratio; CrI: credible interval; DXA: Dual-energy x-ray absorptiometry; 
TSH: thyroid stimulating hormone; DM: diabetes mellitus; POCR: outpatient preoperative 
chest radiography; HbA1c: glycated haemoglobin; LDL: low-density lipoprotein; C-section: 
Caesarean section; BZD: benzodiazepines; PPI: proton pump inhibitor; AMI: acute myocardial 
infarction; Afib: atrial fibrillation; ACE: angiotensin converting enzyme; ARB: angiotensin 
receptor blocker; P2Y: clopidogrel, prasugrel or ticagrelor; PAD: peripheral artery disease; 









We studied 24 diverse healthcare services recommended or discouraged for target populations 
in clinical guidelines, mainly for major chronic diseases. Overall utilization rates varied 
substantially, and suggested suboptimal utilization for many services. After controlling for 
multiple influencing factors, the unexplained regional variation was generally small. 
Associations between health insurance-related characteristics and utilization were mostly 
consistent; associations with other influences were rather service-specific. 
Although there are no “appropriate” or “optimal” utilization rates known for many healthcare 
services, strongly recommended services supported by sound evidence may be considered as 
effective care, and expected to be highly utilized in eligible populations. For example, the 
studied tests for diabetes complications and secondary prevention medications for AMI patients 
would fall into this category. Utilization rates for these services between 34% and 70% 
indicated suboptimal utilization. The utilization rates of healthcare services discouraged in 
clinical guidelines were generally low as expected. However, 55.5% of patients used proton 
pump inhibitors (PPI) for a prolonged time. Avoidance of prolonged PPI use is a top five 
recommendations for outpatient general internal medicine developed by Smarter Medicine - a 
Swiss version of the Choosing Wisely [29]. 
The effects of explanatory variables reflected, to some extent, barriers to and facilitators of 
access to care. In particular, we found coherent associations with health insurance-related 
characteristics, in a setting with mandatory insurance and quasi-universal access. The data 
indicated a negative dose-response effect of deductible level on utilization. People with higher 
deductibles tend to be healthier and willing to take more risks, and some of their invoices may 
be missed, which may partially explain this observation. However, higher out-of-pocket costs 
may also make people more reluctant to use services, constituting a financial barrier [30]. While 
non-insurance practically does not occur in Switzerland, foregoing healthcare utilization due to 
out-of-pocket costs has been previously documented [31-33]. People having supplementary 
insurance in addition to mandatory insurance may be wealthier, and more health-conscious and 
educated on average. Thus, they may seek, or be willing to accept more care, as we observed 
for most services. Having supplementary hospital insurance was in general associated with 
increased utilization of healthcare services. This effect was especially prominent in the case of 
C-section, which is, to a large extent, a preference-sensitive service [34]. Expectedly, having 




surgical procedures, recommended to be performed on an outpatient basis, as inpatients 
Enrolees in managed care models were more likely to use healthcare in two thirds of the studied 
services, which were mostly recommended ones. This may be partially explained by more 
health awareness. It may also imply that managed care models provide better coordinated and 
more guideline-concordant care. 
Associations between socio-demographics and healthcare utilization were largely service 
specific. Effects of language region were not consistent, which may be due to different culture 
and norms, regional health intervention programs, and different practice styles of healthcare 
providers [35, 36].  
People with more comorbidities were generally more likely to use healthcare services. Worse 
health may trigger more awareness of health-related issues and more contact with healthcare 
providers, leading to further care. Exceptions were secondary prevention medications in AMI 
patients and oral anticoagulation in atrial fibrillation patients. Previous studies also reported 
that more comorbidities were associated with poor adherence to related recommendations [37, 
38]. 
SAVA detected six healthcare services with SCV values over three, among which breast cancer 
screening, POCR, and long-term use of benzodiazepines in older people had SCVs around ten, 
suggesting large regional variation. However, after adjusting for available influencing factors, 
all MORs were relatively small (1.14 - 1.49). Together with VPCs below 5%, this indicated 
that the unexplained regional variation in utilization of all considered services was small [22]. 
The largest unexplained variation was found for TSH testing and surgical procedures performed 
in the outpatient setting. Both represent preference-sensitive care and decision-making may 
strongly depend on physicians’ preferences and clinical opinions. Only few previous studies 
have comprehensively assessed and compared variation in utilization across multiple healthcare 
services, with mixed results. One study reported moderate variation with MORs between 1.27 
to 1.74 for some diabetes-related primary care services [7]. Another study reported large 
variation with MORs between 2.3 to 21.5 for intensive care unit (ICU) use after 13 major 
surgical procedures across hospitals [6]. 
In addition to relatively small regional variation across 24 healthcare services, we found 
moderate spatial autocorrelation, that is, spatial dependence in the unexplained regional 
variation in utilization for several healthcare services. Further research could assess the spatial 




and possibly identify regions with generally superior or inferior performance in terms of 
appropriate healthcare utilization. This might provide valuable insights for local healthcare 
intervention and promotion programs.  
Strengths and limitations 
Our study has a number of strengths. First, we used a large dataset representing all regions of 
Switzerland, resulting in large sample sizes for most of the studied healthcare services. Second, 
we assessed multiple, diverse services, enabling comparison and a broader perspective. The 
health insurance claims data used provided detailed information on individual insurance-related 
characteristics, allowing in-depth analyses. Finally, we performed multilevel multivariable 
modelling for efficient control of confounding. 
Several limitations should be considered. First, our selection of healthcare services and eligible 
populations was not entirely based on burden of disease criteria, mainly because of limitations 
dictated by the characteristics of Swiss claims data. Second, clinical information is limited in 
the claims data; outpatient diagnoses are lacking. This may have led to a certain extent of 
misclassification of eligibility for and utilization of services. Third, we used claims data from 
a single insurer. Enrolees of other health insurers may theoretically have different 
characteristics and patterns of healthcare utilization. However, the claims data were based on 
1.2 million people from all regions in Switzerland. The benefit package of the mandatory 
insurance is federally defined and identical for all health insurers. Thus, we expect little 
deviation of enrollees’ characteristics compared to the whole Swiss population, and the results 
should essentially be generalizable to the entire country. Fourth, we cannot exclude high 
variation across different types of units, e.g. healthcare providers for whom we had no detailed 
information. 
Conclusion 
Our study is the first to collectively evaluate regional variation in the utilization of diverse 
healthcare services and related influencing factors, with a particular focus on insurance-related 
characteristics. The observed utilization rates indicated suboptimal utilization for many 
services. Regional variation in utilization that remained unexplained after multivariable 
adjustment was relatively small, implying only limited local variation. With respect to health 
insurance-related characteristics, higher deductible levels were consistently associated with 




insurance, and having supplementary hospital insurance. People having chosen a managed care 
model were generally more likely to use the recommended but not discouraged care, suggesting 
a better coordinated, more guideline-adherent care model. These observations indicate that 
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Figure S1. Relationship between age and healthcare services utilization. 
a. Colon cancer screening                                             b. Breast cancer screening 
   
c. Prostate cancer screening                                          d. Osteoporosis screening 
   
e. DM: HbA1c test                                                        f. DM: kidney exam
   







Figure S1. continued 
g. DM: LDL test                                                            h. DM: eye check 
   
i. TSH test                                                                    j. Influenza vaccination
    
k. BZD                                                                              l. PPI 









Figure S1. continued 
m. Outpatient procedures                                              n. AMI: statin 
   
o. AMI: P2Y                                                                  p. PPI with NSAID 
   
q. PAD: statin                                                                    r. Afib: anticoagulation 
   
DM: diabetes mellitus; HbA1c: glycated haemoglobin; LDL: low-density lipoprotein; TSH: 
thyroid stimulating hormone; BZD: benzodiazepines; PPI: proton pump inhibitor; AMI: acute 
myocardial infarction; P2Y: clopidogrel, prasugrel or ticagrelor; NSAID: nonsteroidal anti-






1. Corallo AN, Croxford R, Goodman DC, et al. A systematic review of medical practice 
variation in OECD countries. Health policy (Amsterdam, Netherlands). 2014;114(1):5-14. 
2. Appleby J, Raleigh V, Frosini F, et al., editors. Variations in health care: the good, the 
bad and the inexplicable.2011. 
3. OECD. Geographic Variations in Health Care2014. 
4. Mercuri M, Gafni A. Medical practice variations: what the literature tells us (or does 
not) about what are warranted and unwarranted variations. Journal of evaluation in clinical 
practice. 2011;17(4):671-7. 
5. Gulliford M, Figueroa-Munoz J, Morgan M, et al. What does 'access to health care' 
mean? Journal of health services research & policy. 2002;7(3):186-8. 
6. Jerath A, Laupacis A, Austin PC, Wunsch H, Wijeysundera DN. Intensive care 
utilization following major noncardiac surgical procedures in Ontario, Canada: a population-
based study. Intensive care medicine. 2018;44(9):1427-35. 
7. Tran DT, Jorm LR, Havard A, Harris MF, Comino EJ. Variation in the use of primary 
care services for diabetes management according to country of birth and geography among 
older Australians. Primary care diabetes. 2016;10(1):66-74. 
8. McPherson K, Wennberg JE, Hovind OB, Clifford P. Small-area variations in the use 
of common surgical procedures: an international comparison of New England, England, and 
Norway. The New England journal of medicine. 1982;307(21):1310-4. 
9. Scheuter C, Wertli MM, Haynes AG, et al. Unwarranted regional variation in 
vertebroplasty and kyphoplasty in Switzerland: A population-based small area variation 
analysis. PloS one. 2018;13(12):e0208578. 
10. Cadarette SM, Wong L. An Introduction to Health Care Administrative Data. The 
Canadian journal of hospital pharmacy. 2015;68(3):232-7. 
11. Neubauer S, Kreis K, Klora M, Zeidler J. Access, use, and challenges of claims data 
analyses in Germany. The European Journal of Health Economics. 2017;18(5):533-6. 
12. Ulyte A, Bähler C, Schwenkglenks M, et al. Measuring diabetes guideline adherence 
with claims data: systematic construction of indicators and related challenges. BMJ Open. 
2019;9(4):e027138. 
13. Blozik E, Signorell A, Reich O. How does hospitalization affect continuity of drug 




14. Reich O, Rapold R, Flatscher-Thoni M. An empirical investigation of the efficiency 
effects of integrated care models in Switzerland. International journal of integrated care. 
2012;12:e2. 
15. Huber CA, Szucs TD, Rapold R, Reich O. Identifying patients with chronic conditions 
using pharmacy data in Switzerland: an updated mapping approach to the classification of 
medications. BMC public health. 2013;13:1030. 
16. Bundesamt für Statistik. MS-Regionen. Switzerland 2016 [Available from: 
https://www.bfs.admin.ch/bfs/de/home/statistiken/raum-
umwelt/nomenklaturen/msreg.assetdetail.415729.html. 
17. Shwartz M, Ash AS, Anderson J, et al. Small area variations in hospitalization rates: 
how much you see depends on how you look. Medical care. 1994;32(3):189-201. 
18. McPherson K, Downing A, Buirski D, et al. Systematic variation in surgical procedures 
and hospital admission rates : a methodological study; report II, April 1996 for the Department 
of Health.1996. 
19. Srinivasan S. Local and Global Spatial Statistics.  Encyclopedia of GIS. Boston, MA: 
Springer US; 2008. p. 615-. 
20. Wei W, Gruebner O, von Wyl V, et al. Variation of preoperative chest radiography 
utilization in Switzerland and its influencing factors: a multilevel study with claims data. 
Scientific reports. 2018;8(1):17475. 
21. Spiegelhalter DJ, Best NG, Carlin BP, Linde AVD. Bayesian measures of model 
complexity and fit. Journal of the Royal Statistical Society Series B (Statistical Methodology). 
2002;64(4):583-639. 
22. Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression 
analysis. Statistics in medicine. 2017;36(20):3257-77. 
23. Moran PAP. The Interpretation of Statistical Maps. Journal of the Royal Statistical 
Society: Series B (Methodological). 1948;10(2):243-51. 
24. MORAN PAP. NOTES ON CONTINUOUS STOCHASTIC PHENOMENA. 
Biometrika. 1950;37(1-2):17-23. 
25. David J. Spiegelhalter NGB, Bradley P. Carlin, Angelika Van Der Linde. Bayesian 
measures of model complexity and fit. Journal of the Royal Statistical Society Series B 
(Statistical Methodology). 2002;64(4):583-639. 
26. Rue H, Martino S, Chopin N. Approximate Bayesian Inference for Latent Gaussian 
Models by Using Integrated Nested Laplace Approximations. Journal of the Royal Statistical 




27. Leckie, G. and Charlton, C. 2013. runmlwin - A Program to Run the MLwiN Multilevel 
Modelling Software from within Stata. Journal of Statistical Software, 52 (11),1-40. 
28. Anselin L, Syabri I, Kho Y. GeoDa: An Introduction to Spatial Data Analysis. In: 
Fischer MM, Getis A, editors. Handbook of Applied Spatial Analysis: Software Tools, Methods 
and Applications. Berlin, Heidelberg: Springer Berlin Heidelberg; 2010. p. 73-89. 
29. SSGIM. Top Five List for Choosing Wisely in the Outpatient General Internal Medicine 
2016 [Available from: https://www.smartermedicine.ch/de/top-5-listen/ambulante-allgemeine-
innere-medizin.html. 
30. Guessous I, Gaspoz JM, Theler JM, Wolff H. High prevalence of forgoing healthcare 
for economic reasons in Switzerland: a population-based study in a region with universal health 
insurance coverage. Preventive medicine. 2012;55(5):521-7. 
31. Johansson N, Jakobsson N, Svensson M. Effects of primary care cost-sharing among 
young adults: varying impact across income groups and gender. The European journal of health 
economics : HEPAC : health economics in prevention and care. 2019;20(8):1271-80. 
32. Maynou L, Coll-de-Tuero G, Saez M. The effects of copayment in primary health care: 
evidence from a natural experiment. The European journal of health economics : HEPAC : 
health economics in prevention and care. 2019;20(8):1237-48. 
33. Wolff H, Gaspoz JM, Guessous I. Health care renunciation for economic reasons in 
Switzerland. Swiss medical weekly. 2011;141:w13165. 
34. Wennberg JE. Tracking Medicine: Oxford University Press; 2010. 344 p. 
35. Delco F, Michetti P, Beglinger C, Fried M, Szucs TD. Health care resource utilization 
and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland. 
Digestion. 2004;69(1):10-9. 
36. Panczak R, Luta X, Maessen M, et al. Regional Variation of Cost of Care in the Last 12 
Months of Life in Switzerland: Small-area Analysis Using Insurance Claims Data. Medical 
care. 2017;55(2):155-63. 
37. Manzoor BS, Lee TA, Sharp LK, et al. Real-World Adherence and Persistence with 
Direct Oral Anticoagulants in Adults with Atrial Fibrillation. Pharmacotherapy. 
2017;37(10):1221-30. 
38. Shang P, Liu GG, Zheng X, et al. Association Between Medication Adherence and 1-
Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China. 

















































The following discussion summarizes the main findings of the thesis and discusses the 
contribution to health services research especially regional variation analysis in healthcare 
utilization, and the significance of the findings in providing important implications to the 
healthcare system. 
The thesis proposed a comprehensive analysis approach for study on regional variation in 
healthcare utilization based on existing methods. It was developed using preoperative chest 
radiography (POCR) as a test case, the routine use of which is discouraged in international 
clinical guidelines [1], and also the Choosing Wisely initiatives [2, 3]. The analysis approach 
consisted of small area variation analysis for describing unadjusted regional variation, 
multilevel regression modelling for investigating influencing factors, calculation of median 
odds ratio for assessing adjusted regional variation, spatial autocorrelation analysis using 
Moran’s I statistic, and visualization of regional variation through mapping with geographic 
information system (GIS) applications.  
By applying the comprehensive analysis approach to regional variation analysis in the 
utilization of four management measures strongly recommended to diabetes patients [4-6], I 
further extended multilevel regression modelling by taking spatial autocorrelation into account. 
This was achieved by applying the Bayesian statistical model through the Integrated Nested 
Laplace Approximations (INLA) approach [7-9]. However, this additional step has not been 
performed in analysis for other selected healthcare services. There are several reasons. First, 
performing the INLA model needs a large number of small regions, requiring a relatively big 
size of the study population that would cover all these regions across the whole of Switzerland. 
Only Medstat regions (N=705) [10] could be used for such analysis, however, the study 
populations for around one-third of selected healthcare services were under 10,000, leading to 
no eligible persons present in many Medstat regions. Besides, analysis results showed 
insignificant or little spatial autocorrelation in multilevel model residuals for most healthcare 
services, suggesting healthcare utilization was mostly independent across regions therefore a 
further correction would not be necessary. To make the analysis approach consistent and results 
comparable across all selected services, spatial multilevel modelling analysis was conducted as 
an extra step only for healthcare services for diabetes patients. Figure 1 shows the 
comprehensive analysis approach including the INLA model for assessing regional variation in 





Figure 1. A comprehensive approach for analysis of regional variation in healthcare 
utilization 
 
SAVA: small area variation analysis; EQ: extremal quotient; IQR: interquartile range; CV: 
coefficient of variation; SCV: systematic component of variation; MOR: median odds ratio; INLA: 
Integrated Nested Laplace Approximations. 
 
Compared to the conventionally used analytical method in regional variation analysis of 
healthcare utilization, the comprehensive approach proposed in this thesis has many advantages. 
First, it supplements small area variation analysis (SAVA) which assesses the degree of only 
unadjusted or partially adjusted regional variation. Calculation of median odds ratio and 
variance partition coefficient enables the assessment of regional variation after adjustment for 
multiple influencing factors. Second, multilevel regression analysis taking the random effect at 
region level into consideration allows for a thorough investigation into the effects of different 
influencing factors with less bias. In addition, it is convenient to perform a cross-services 
comparison. Not only unadjusted and adjusted regional variation, but the effects of influencing 
factors can be easily summarized and compared graphically across diverse healthcare services, 
making it possible to identify potential common patterns. Finally, although spatial multilevel 
regression analysis with the INLA approach has not been generally applied in the present thesis, 




which could play an important role in future similar research when considerable spatial 
autocorrelation appears in healthcare utilization across regions [11]. 
The 24 diverse healthcare services in this thesis were selected based on a systematic approach 
considering many aspects especially the related clinical practice guidelines [12]. This 
systematic selection approach was developed within the first part of our NRP74 project, in 
which the present thesis is nested. Recommendation statements from clinical practice 
guidelines used in Switzerland were considered pragmatically according to clinical relevance, 
expected frequency of service use, size of the eligible population, and feasibility to identify the 
population and service from Swiss health insurance claims data. The selected services mainly 
focused on common chronic diseases. They also had a good coverage of different kinds of 
healthcare services, ranging from screening, diagnosis, primary prevention, treatment, to 
secondary prevention; from lab tests, imaging, drug prescriptions, to surgical procedures. 
Therefore, the findings are expected to have relatively good generalizability due to the great 
diversity of studied services. To the best of our knowledge, the present thesis is the first to 
analyse regional variation in the utilization of diverse healthcare services that were elaborately 
selected through a self-developed systematic approach. 
It has been observed that the overall utilization rates varied remarkably across services, showing 
suboptimal utilization in many services, especially the effective ones which are strongly 
recommended in clinical practice guidelines. After multivariate adjustment, regional variation 
was generally small in the utilization of all selected services. Multiple factors were significantly 
associated with healthcare utilization, however, the most interesting finding was the consistent 
effects of health insurance-related factors among most selected services. A higher annual 
deductible level was mostly associated with lower utilization. Supplementary insurance, 
supplementary hospital insurance, and choosing a managed care model were associated with 
higher utilization of most services. Managed care models showed a tendency towards more 
recommended care. 
The healthcare system in Switzerland has relatively universal care access and high out-of-
pocket expenditures. Universal access to care is reflected to a certain extent by generally small 
regional variation in the utilization of all selected healthcare services observed in our study. 
However, high out-of-pocket payment from the patient, which has been shown to be a financial 
barrier to the utilization of healthcare services [13], might be one of the reasons for the reported 
suboptimal utilization of many healthcare services. People choosing a higher annual deductible 




phenomenon needs to be regarded from two perspectives - healthcare services with positive or 
negative recommendations. On the one hand, for effective cares strongly recommended in 
guidelines such as colorectal cancer screening and diabetes management measures, high 
deductible could result in potential underuse; on the other hand, low deductible may lead to 
overuse of healthcare services that are not cost-effective and discouraged in guidelines, for 
example, the routine use of preoperative chest radiography. Our findings indicate that more 
appropriate healthcare utilization and a better-performed healthcare system in terms of equity, 
quality, and efficiency might be achieved through adjustment of insurance scheme design. More 
specifically, further financial incentives could be considered to encourage some better 
coordinated and more guideline-adherent care models, like managed care models; and the 
annual deductible policy might also be slightly adjusted to be more flexible taking healthcare 
types (effective care, care with debatable evidences, and non-recommended care) into 
consideration.  
Further research 
The present thesis has addressed to a large extent the common issues of previous studies on 
regional variation in healthcare utilization described in the introduction section, however, there 
are still certain limitations mainly due to the claims data. Although a systematic approach was 
adopted to select healthcare services, the final selection was largely limited by the 
characteristics of Swiss claims data. Some information is not available from claims data, for 
example, the outpatient diagnoses are lacking; there is very little information on healthcare 
providers’ characteristics which is also partially because of data protection rules; and the patient 
and physician preferences cannot be captured.  
To overcome these limitations, future studies could consider using combined data from 
different sources, for example, information of patients and physicians’ preferences could be 
integrated from survey data which requires a different type of research such as qualitative or 
mixed methods. Besides, data protection policy for healthcare administrative data might be 
slightly adjusted to reach a better balance between privacy protection and scientific research. 
Other directions for further research include: first, time trend analysis to explore the change of 
regional variation in healthcare utilization over time. Currently, data from the year 2014 was 
used in the present thesis, and data from two additional time points (year 2016 and 2018) is 




potential overarching spatial clustering patterns in the utilization of multiple healthcare 
services, and identifying specific regions with generally superior or inferior performance. 
Research findings on potential problematic regions may provide insights into better healthcare 
resource allocation and the planning and implication of local health promotion and intervention 
programs. 
Concluding remarks 
To summarize, the presented thesis is the first to simultaneously assess regional variation in the 
utilization of multiple healthcare services with great diversity. The consistent effects of health 
insurance-related factors on healthcare utilization and variation worth special notice, suggesting 
more appropriate healthcare utilization with less unwarranted variation and a better-performed 
healthcare system may be potentially achieved through adjustment of health insurance design. 
Moreover, our comprehensive analysis approach allows for assessing unadjusted and adjusted 
regional variation in healthcare utilization, investigating thoroughly the effects of influencing 
factors, and more importantly, comparing results across various healthcare services for 
exploration of potential consistency. It aids in the identification of regional variation and 
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